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The following research portfolio is comprised of a systematic review entitled ‘The association 
between Post Traumatic Stress Disorder and Substance use Disorder: A Systematic Review’ 
(Chapter 1).  Following this review of the wider literature, an empirical research project was carried 
out to explore motives for substance use in the presence of Post Traumatic Stress Disorder.  The 
portfolio presents a brief rational for the empirical project (Chapter 2) followed by the study aims 
and hypotheses.  Chapter three provides a detailed description of the methods used to conduct the 
empirical project. The empirical project is reported in the form of a journal article (Chapter 4) 
entitled ‘Motives for substance use in the presence and absence of Post Traumatic Stress Disorder 
(PTSD)’.  This is followed by an extended results and discussion section (Chapter 5).  In the final 
chapters, consideration is given to the strengths and limitations of the study, the clinical 
implications of the findings, and directions for future research.   
 

































Background: Post Traumatic Stress Disorder (PTSD) is frequently linked with substance use 
disorder (SUD).  However, the nature of this association remains unclear.  A clearer understanding 
of the dynamic associations between PTSD and SUD may shed light on the course of these two 
disorders thereby, identifying areas for intervention, which may potentially reduce some of the 
associated costly and harmful outcomes.  
 
Methods: Firstly, a systematic review was conducted to investigate the evidence base regarding the 
relationship between PTSD and SUD.  Secondly, an empirical project was undertaken to explore 
functional associations between PTSD and SUD. This was achieved by comparing, motives for 
substance use, anxiety and depression symptoms, and SUD symptom severity amongst treatment-
seeking adults with and without PTSD.  
 
Results: Results from the systematic review suggest that individuals with comorbid PTSD and 
SUD have more severe clinical profiles compared to individuals with a SUD alone.  The results 
from the empirical study indicate that those with PTSD endorse coping-related motives for 
substance use significantly more than those without PTSD. Furthermore, those with PTSD had 
significantly elevated SUD severity ratings and higher anxiety and depression scores.   
 
Conclusions: Findings suggest that individuals with comorbid PTSD and SUD are motivated to use 
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The association between Post Traumatic Stress Disorder and Substance use 




Background: Substance use disorders (SUD) are highly prevalent amongst 
individuals with Post Traumatic Stress Disorder (PTSD). High rates of comorbidity 
suggest that PTSD and SUD are functionally related to one another.  However, there 
is currently a lack of systematic reviews regarding the nature of the relationship 
between SUD and PTSD.   
 
Objective: The objective of this systematic review is to summarise the literature 
investigating the association between PTSD and SUD, bearing in mind the 
methodological rigor of the studies retrieved when considering their findings.   
 
Results 776 articles were identified in the search for relevant articles of which 18 met 
the inclusion criteria.  Relations were found between PTSD, substance use, 
psychiatric symptoms and depression scores.   
 
Conclusions PTSD and SUD are significantly associated with each other.  However, 
the nature of this association remains unclear.  Future research investigating potential 








It has been well established in both clinical and epidemiological studies that there is a 
high prevalence of comorbidity between Post Traumatic Stress Disorder (PTSD) and 
substance use disorder (SUD) (Howard et al., 1998; Jacobsen et al., 2001) (see 
Chapter 2, section 5 for definitions of PTSD and SUD).  Numerous investigations, 
incorporating a variety of study designs and sample types have documented evidence 
of this association.   In the general population, studies indicate that approximately 3.6 
per cent of individuals are affected by PTSD (McCrone et al., 2003).  Such studies 
also indicate that levels of lifetime substance misuse in the general population vary 
from 8.1 to 24.7 per cent (Shora et al., 2009) and that this increases to between 21.6 
and 43 per cent in those with PTSD (Kessler et al., 1995).  For individuals in 
treatment for SUDs, it has been demonstrated that between 30 per cent and 75 per 
cent meet the diagnostic criteria for lifetime PTSD and 11 to 60 per cent for current 
PTSD (e.g. Brady, et al., 1994; Jacobsen et al., 2001; Najavits, 2005).    
 
The high prevalence of comorbid PTSD and SUD presents a significant challenge to 
service providers (Najavits, 2002).  For instance, research in this area indicates that 
patients presenting with PTSD and SUD have poorer treatment prognoses (Ford et al., 
2007), higher rates of co-occurring mental health disorders (Schafer and Najavits, 
2007), a greater number of medical and interpersonal problems (Back et al., 2009) and 
a higher use of services (Brown et al., 1995) compared to those presenting with PTSD 
or SUD only. 
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It has been suggested that high rates of comorbidity indicate the presence of a 
functional association between PTSD and SUD (Jacobsen et al., 2001).  Several 
pathways have been described to try and explain the association between PTSD and 
SUD (for a full review see Stewart, 1996; Stewart and Concord, 2003).  The majority 
of research regarding causal pathways between PTSD and SUD supports the idea that 
substance use follows or coincides with traumatic exposure and the development of 
PTSD (Keane and Kaloupek, 1998; Jacobsen et al., 2001).  According to this model, 
substance use is viewed as a means of self-medicating.  The „self-medication‟ 
hypothesis (Khantzian, 1997) suggests that individuals use substances in an attempt to 
reduce distressing psychiatric symptoms (Villagonzalo et al., 2011).  Thus, those with 
PTSD may be motivated to use substances in an attempt to regulate or escape PTSD 
symptoms of re-experiencing, hyperarousal and avoidance (Tull et al., 2010).  In light 
of such a hypothesis, researchers have investigated variables such as patient‟s 
perceptions (Clark and Jacob, 1992) and motives (Dixon et al., 2009) for substance 
use, order of onset (Mills et al., 2006), severity of substance use and PTSD symptoms 
(Back et al., 2000), choice of substances used (Jacobsen et al., 2001) and triggers for 
substance use (Waldrop et al., 2007).     
 
Conclusions from the available evidence regarding the relationship between PTSD 
and SUD can only be drawn carefully due to methodological limitations (Driessen et 
al., 2008). For example, there is insufficient information available regarding the 
association between PTSD and particular substances (Mills et al., 2006).  In many 
studies, diagnoses often remain unclear, for example, alcohol versus drug disorders, 
substance misuse versus SUD, and suspected versus definite PTSD (Driessen et al., 
2008).  Additionally, many comorbid studies have focused on individuals exposed to 
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particular forms of trauma (Stewart, 1996), making it difficult to reach general 
conclusions about the relationship between trauma exposure, PTSD and SUD across 
traumatic events. Furthermore, in many studies there tends to be a general lack of use 
of control groups, particularly in earlier research (Stewart, 1996).  
 
Despite the growing body of literature investigating and substantiating the linkage 
between PTSD and SUD, there is a lack of systematic reviews regarding the 
mechanisms underlying this association. Reviews in the area have either not been 
systematic (e.g. Stewart, 1996) or have had a narrow focus (e.g. Jacobsen et al., 
2001).    A clearer understanding of the dynamic associations between PTSD and 
SUD may shed light on the course of these two disorders, thereby identifying areas 
for intervention (Grottfredson and Wilson, 2003) which may potentially, reduce some 
of the associated costly and harmful outcomes (Najavits, 2002).   
 
The present review will focus on the methodological quality of studies examining the 
relationship between PTSD and SUD.  Additionally, particular attention will be given 
to studies that explore factors that perhaps mediate, moderate or better account for the 
relationship between PTSD and SUD.  In short, the primary goal of this review is to 





Available guidelines for undertaking systematic reviews, such as the ones outlined by 
the Center for Reviews and Dissemination (CRD), The University of York 
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(www.york.ac.uk/inst/crd/) and the Scottish Intercollegiate Guidance Network (SIGN) 
are aimed at evaluating studies focusing on interventions.  As such, reporting in this 
systematic review was based on existing guidance but adapted to suit the review topic. 
 
Studies were identified via a systematic search strategy and then assessed using 
quality criteria developed from a combination of guidelines provided by the CRD and 
SIGN (see section 2.4).   
 
2.1 Literature search strategy 
 
Relevant articles for this review were identified using a combination of electronic 
databases, citation and reference list searches (Petticrew and Roberts, 2006). 
 
Searches were limited to studies published in English because of lack of feasibility for 
translation of texts. The literature search was initially conducted in October 2011.  
The Ovid databases (1949-2011), EMBASE (1980-2011) and EBSCO collections 
(CINAHL Plus with Full Text, MEDLINE with Full Text, PsycINFO, and the 
Psychology and Behavioural Sciences Collection (1951-2011)) were searched.  
Searches were conducted within the domains of title, abstract and keywords. Searches 








1. [Comorbidity] OR [Relationship] OR [Association] AND 
2. [Post Traumatic Stress Disorder] OR [Trauma] AND 
3. [Substance use disorder] OR [Substance related disorders] OR [Addiction]  
 
Initial searches also encompassed the following search terms. 
 
4. [Substance relapse] OR [Course of illness] OR [Order of onset] OR 
[Individual differences] OR [Motives] OR [Expectations]  
 
These later search terms were not mapped and no search limits were imposed during 
the final searches in order to obtain a comprehensive selection of potential studies for 
the review.  These same databases were then searched again using the same search 
string in January 2012 to account for any relevant articles published since the duration 
of the original literature search. The removal of duplicates left a total of 776 
potentially relevant papers. 
 
 
The titles and abstracts of these 776 potentially relevant studies were screened for 
initial assessment of their suitability according to the predefined inclusion and 
exclusion criteria, outlined in Table 1.  Papers where it could be clearly ascertained 
from the title and/or abstract that they were irrelevant or did not meet the inclusion 
criteria were excluded. These were articles that focused on trauma exposure, articles 
that included a non-treatment seeking population, or articles where the primary aim 
was to investigate biological factors, other major comorbidities and to develop or test 
the psychometric properties of an assessment instrument.  A full-text review of the 
remaining 24 papers was then conducted.  At this stage, two papers were excluded as 
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result of the same data set being used in another two studies.  In both incidences, the 
most recent studies were included in the review.  Additionally, three studies were 
excluded that were carried out prior to 2000.  This was to allow the review to focus on 
the most up-to-date literature.  This resulted in a total of 12 papers, which met the 
inclusion criteria.  The reference lists of the remaining 12 articles were then searched.  
This produced a further six papers that satisfied the inclusion criteria.  The reference 
lists of these six papers were also checked, however, no further articles were 
identified.  The final review was based on the remaining 18 studies.  The flow of the 




















































































Figure 1.  Flow diagram of papers included and excluded at each search stage 
Potentially relevant 
studies screened for 
inclusion: 776 
Full-text articles 




Total articles eligible: 
12 
Search of eligible 
reference lists 
produced a further 12 
potential articles 
Articles included in 
review: 18 
Excluded studies from 
screening title & abstract: 
752 
Exclusion Reasons: 
- Topic irrelevant to review 
(N = 678) 
- Did not meet inclusion 
criteria  
- Dissertations, review 
articles, editorials, opinion 
pieces, book chapters, 
discussions (N = 74) 
 
 
Excluded studies after reading 
article: 12 
Exclusion Reasons: 
- Study used same data set as 
another (N = 2) 
- Study pre 2000 (N = 3) 
- Sample not treatment seeking 
for PTSD/SUD (N = 5) 
- No examination of PTSD 
 (N =1) 
- Focus on other major 
comorbidity (N = 1) 
 
Excluded studies after reading 
article: 6 
Exclusion Reasons: 
-Focus on trauma only (N = 2) 
-Sample not treatment seeking for 
PTSD/SUD (N = 1) 
-Review article (N = 1) 
-Description & discussion of 
treatment approach (N = 1) 
-Focus on other major 




2.2 Inclusion and exclusion criteria 
 
All studies that contained information regarding the association between PTSD and 
SUD were considered for inclusion in the review.  In order to develop a 
comprehensive picture of the relationship between PTSD and SUDs, with the 
exception of single case studies, review and dissertation studies, all other types of 
study designs were considered for inclusion.  This was considered necessary given the 
variety of study designs employed within the research investigating the nature of the 
relationship between PTSD and SUD. 
 
Included studies were based solely on adult participants (within the age range of 18–
65 years) with an explicit diagnosis of PTSD (regardless of type of traumatic event) 
and SUD. The presence of PTSD or SUD was based upon either a structured clinical 
interview for assessment of a diagnosis according to DSM-IV or ICD-10 criteria, or 
indicated by validated assessment scales adopting cut-off scores to establish clinically 
significant symptomatology.  In order for findings to be relevant to the target 
population, studies were excluded if participants were not treatment seeking and/or in 
treatment for either of the disorders.  Only studies focusing on comorbid PTSD and 
SUD were included with studies focusing on either trauma exposure only and/or other 
major comorbidities (e.g., psychosis) being excluded.    
 






Table 1 - Inclusion and Exclusion Criteria 
Inclusion: 
1. Studies that include a comorbid PTSD and SUD population 
2. Population must be treatment seeking/in treatment for PTSD and/or SUD 
3. Studies published in English and in peer-reviewed journals 
4. Participants must be aged between 18 and 65 years of age 
Exclusion: 
1. Studies only investigative trauma exposure 
2. Single case studies 
3. The primary aim of the study was to develop or test the psychometric 
properties of a new assessment instrument 
4. The primary aim of the study was to examine biological factors (e.g., MRI, 
genetics), psychophysiology, or information processing related to PTSD and 
SUD  
5. Studies focusing on other major comorbidities  




2.3 Data Extraction 
 
The key findings and characteristics of the included articles were summarised in 
relation to the purpose of the current systematic review.  A number of the reviewed 
articles investigated variables and carried out statistical analyses that were irrelevant 
to the purpose of the current review (CRD, 2009).  As such, all papers were reviewed 
and the information pertinent to the current review objective was extracted.  The 




2.4 Assessment of quality of included studies  
 
Numerous quality assessment tools exist for systematic appraisal of intervention 
studies or randomised controlled trials (RCTs).  Indeed, between 25 and 60 quality 
assessment tools are available (Moher at al., 1995; Verhagen et al., 2001).  However, 
quality assessment tools to appraise non-intervention studies are less established 
(Sanderson et al., 2007).  This is possibly the result of the widely held view that RCTs 
are the „gold-standard‟ of research designs (Simon, 2001).  Despite this view, the 
evidence base requires knowledge about the aetiology of mental health problems, 
which typically stems from observational research (Black, 1996).  Given that quality 
assessment tools permit systematic appraisal and evaluation of research, it appears 
valid to apply the use of such methods in the evaluation of non-intervention research.       
 
The CRD recommends that quality criteria should encompass an assessment of: the 
risk of bias; the choice of outcome measure; statistical issues; and quality of reporting.  
Drawing on these themes and considering the review topic, in order to assess the 
quality of the studies included in this systematic review, a combination of checklists 
was employed.  In accordance with the available guidance and with consideration 
given to the review topic, the current review utilised a checklist of 10 quality criteria 
identified a priori, which are outlined in Table 3.  The 10 quality criteria were 
assessed in accordance with six outcome ratings as used by the Scottish 
Intercollegiate Guidance Network (SIGN) for assessing the methodological quality of 
research.  The author classified each of the 10 quality criteria for each study in terms 
of one of the following six outcome ratings: „well covered‟ (2 points); „adequately 
addressed‟ (1 point); and „poorly addressed‟, „not addressed‟, „not reported‟ and „not 
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applicable‟ (all 0 points).  Therefore, each paper was given a rating out of 20, with 
higher scores indicating superior quality. Papers that met 75 per cent of the 
methodological criterion specified were considered to be of „high‟ quality. Papers that 
met between 50 per cent and 75 per cent were deemed to have a „moderate‟ quality 
rating and those studies that achieved less than 50 per cent quality rating were 
considered to be of „lower‟ quality.  Quality ratings for each of the included studies 






































Table 3 - Methodological Quality Criteria Checklist:  
 






1. Does the study have a clearly focused question? 
0 = The aims or hypotheses were not clearly stated 
1 = The aims were clearly stated but not the hypotheses 
2 = The aims and hypotheses were clearly described  
 
   
2. Was the reliability of the diagnoses in question 
(PTSD/SUD) clearly outlined? 
0 = Not explicit or assessed 
1 = parts of standardised interview used to develop own 
interview/questionnaires alone 
2 = standardised interview/standardised interview plus 
questionnaires 
   
3. What variables were examined that may account for 
the link between PTSD and SUD? (e.g. individual 
differences/symptom severity/substance use expectations 
etc) 
 0 = not explicit/not relevant/broad range of variables   
considered 
1 = moderate focus of specific variables 
2 = specific, well documented range of variables considered  
 
   
4. How were variables that may account for the link 
between PTSD and SUD assessed?  
0 = self report in an interview only; non-standardised tools; 
not explicit 
1 = Mixture of self report via interview and standardised 
self report tools  
2 = only standardised self report tools; measures used are 
the best available for the author’s purpose.       
   
5. Are the characteristics of the participants included in 
the study clearly described? 
0 = none/vague 
1= brief/fair description (e.g. demographics/1-2 variables 
described) 
 2 = good description (e.g. treatment length, time since 
diagnosis, current substance use etc/>2 variables 
documented) 
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6. Were the inclusion & exclusion criteria clearly defined 
and did this result in representation of the target 
population?  
0 = Not stated/Sample is very different from the patients 
seeking treatment for either disorder (e.g. there is unfair 
exclusion criteria). 
1 = Referred to but not clearly stated/Sample is somewhat 
representative of patients seeking treatment for this 
comorbid disorder (e.g. patients were only excluded if they 
met criteria for other major disorders). 
2 = Clearly stated/Sample is very representative of patients 
seeking treatment for either disorder (e.g. authors made 
efforts to ensure representativeness of the sample).  
   
7. What was the method of selection of the target 
population? 
0 = Not stated 
1 = Highly selective sample (e.g. consecutive sample from a 
highly pre-selected group i.e. involved in another study) 
2 = consecutive sample of convenience/ random selection  
   
8. Was a power calculation used or sample size justified? 
0 = Not completed/under powered 
1 = Issues regarding power or sample size 
acknowledged/findings or post hoc calculation of power 
completed but a prior analysis not completed/explained 
2 = A prior sample size calculation completed and the study 
was sufficiently powered.  
   
9. Statistical analysis and presentation of results  
0 = Inadequate statistical methods were used and/or data is 
not fully presented. 
1 = Adequate statistical methods were used but data are not 
fully presented. 
2 = Adequate statistical methods were used and data is fully 
presented 
   
10. Are the findings presented in light of the available 
literature/theory? 
0 = little or no attempt to link findings to theory 
1 = findings discussed in light of available evidence but no 
firm conclusions drawn and/or recommendations made  
2 = findings discussed in light of available evidence and 
firm conclusions drawn and/or recommendations made  





2.5 Reliability of quality rating  
 
To assess the reliability of this tool, a second reviewer (Z.H) using the same tool rated 
nine of the final 18 papers. These included papers of high (N = 1), medium (N = 6) 
and low (N = 2) methodological quality. Overall percentage agreement was high (78 
per cent). Discrepancies in ratings were resolved by the author and independent rater 
meeting to discuss and review disagreements with amendments made where 
appropriate.   
 
2.6 Data Synthesis 
 
As recommended by the CRD (2009), a narrative synthesis was conducted whilst 
assessing the quality of papers included in this review.  The aim is to provide an 




3.1 General overview of papers 
 
The 18 studies included in the review ranged in sample size from 48 to 615 
participants.  Two studies included male participants only and one study included 
females only.  The majority of the research was conducted in America (N = 13), with 
two studies carried out in Australia, one in the UK, one in Istanbul and one in 
Germany. All participants were treatment seeking and/or in treatment for either of the 
comorbid conditions under investigation.  Reporting of participant demographics 
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varied between studies.  In general, the majority of participants had poor educational 
attainment and were unemployed.  Data collection methods included a mixture of 
standardised self-report measures, structured interview schedules and questionnaires 
that were adapted and/or developed specifically for the investigation in hand.   All of 
the 18 studies investigated the association between PTSD and SUD.   
 
Most of the included studies discussed their findings in light of the „self-medication 
hypothesis‟ (Khantizan, 1997).  Alternative hypothesis were considered in several 
articles (Back et al., 2006; Hien et al., 2010; Norman et al., 2007; Reynolds et al., 
2004; Smith et al., 2010; Villagonzalo et al., 2011).  Such as the „high-risk 
hypothesis‟, which suggests that substance use increases the likelihood that 
individuals will be exposed to traumatic experiences, thereby increasing the risk of 
developing PTSD (Back et al., 2006).  However, results appeared to provide the 
greatest support for the idea that those with PTSD use substances in an attempt to 
alleviate the associated distressing symptoms.      
 
The methodological quality of the reviewed papers was variable (see Appendix 3, 
Table 4).  Two studies were of „high‟ quality (Driessen et al., 2008; Hien et al., 2010), 
13 were „moderate‟ (Back et al., 2006; Back et al., 2000; Back et al., 2005; 
Bornovalova et al., 2009; Clark et al., 2001; Evren et al., 2010; Mills et al., 2006; 
Norman et al., 2007; Reynolds et al., 2004; Simpson et al., 2006; Smith et al., 2010; 
Tull et al., 2010; Villagonzalo et al., 2011) and three were of „low‟ methodological 
quality (Ouimette et al., 2007; Read et al., 2004; Waldrop et al., 2007). Studies are 
reviewed below in order of their quality rating.  It was deemed necessary to structure 
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the review of the included articles in this way given the variety of study designs 
employed and due to the lack of an identified single comparator between studies. 
 
3.2 High Quality  
 
Hein and colleagues (2010) carried out a RCT with participants being randomised into 
either a six-week „trauma-focused group‟ or a six-week „health education group‟.  
Participants in both groups were classified at baseline as being abstinent, light 
substance users or heavy substance users.  The temporal course of improvement in 
symptoms of PTSD and SUD were investigated during the six-week treatment phase 
of the study and at 1 week, 3 months, 6 months and 12 months follow up.  Findings 
from week-to-week analyses and longitudinal follow up indicated that improvements 
in PTSD symptoms were associated with subsequent reductions in substance use. 
There was limited evidence that improvements in SUD were associated with PTSD 
symptom improvements.  Furthermore, trauma-focused treatment was found to be 
significantly more effective in achieving substance use improvement than the 
comparison treatment.  However, this finding was limited to those classified as heavy 
substance users at baseline who had achieved significant PTSD reductions.  As such, 
Hein and colleagues suggest that those classified as abstinent at baseline benefited 
less from a focus on PTSD symptoms as related to substance use behaviours 
compared to those with active substance use.    Several limitations must be taken into 
consideration when interpreting the results of this study.  Firstly, 40 per cent of 
participants were abstinent at baseline, which restricted the variability in drug and 
alcohol outcomes.  As such, overall treatment effects may have been diluted.  
Furthermore, the vast majority of participants met criteria for drug abuse or 
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dependence.  Therefore, findings may not be applicable to a primarily alcohol-
dependant sample. The sample consisted of females only, which further reduces the 
generalisability of findings. Additionally, participants were also receiving treatment 
related to substance abuse, which may have impacted on the outcomes.  
 
Driessen and colleagues (2008) investigated the relationship between PTSD and the 
severity and course of addiction and psychopathology.  This association was explored 
in patients with PTSD, subsyndromal PTSD (defined as being assessed by one 
standardised instrument only) and those with a history of trauma exposure without 
PTSD. This was achieved by comparing individuals with alcohol dependence, drug 
dependence, or both separately.  Higher rates of PTSD were observed in the drug 
dependent and combined alcohol and drug dependent groups compared with the 
alcohol dependent group.   Compared to all other groups, those with PTSD had higher 
psychopathology ratings, addiction severity scores, more frequent cravings during the 
previous month, a greater number of SUD-related hospital admissions, and shorter 
periods of abstinence from drugs following previous treatments.  Furthermore, an 
earlier onset of alcohol dependence symptoms was found amongst those with PTSD 
as compared to those with subsyndromal PTSD and the trauma exposed group. In 
general, PTSD was found to be an independent risk factor of a worse course and 
outcome of substance dependence. Clearer associations were observed between 
variables when PTSD was diagnosed with more than one instrument.  Given that part 
of this study investigated the effect of how PTSD is assessed, one limitation relates to 
the lack of use of a structured interview to diagnose PTSD.  Furthermore, the number 
of statistical tests carried out may have increased the chance of a type one error.   
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3.3 Moderate Quality 
 
In line with Hein and colleagues (2010), two of the studies rated as having „moderate‟ 
methodological quality (Back et al., 2006; Back et al., 2005) investigated the temporal 
course of improvement in PTSD and SUD symptoms.  Back et al. (2006) found that 
improvements in PTSD symptoms were associated with improvements in alcohol 
dependence symptoms and that this association was greater than for the reciprocal 
relationship.   In particular, Back et al. (2006) reported that improvements in 
hyperarousal PTSD symptoms were related to substantially improved alcohol use.  
However, Back et al. (2006) also reported that alcohol symptoms tended to start 
improving either before or in conjunction with PTSD symptoms.  Similarly, Back and 
colleagues (2005) findings suggest that as alcohol consumption decreases so do PTSD 
symptoms.  As such, there appears to be mixed evidence in relation to the temporal 
course of improvements in PTSD and SUD symptoms.  Several explanations may 
account for such discrepancies.  For instance, the Back et al. (2005) study was 
designed as a medication trial and as such any improvements in symptoms could be 
attributed to the effects of this.  Furthermore, Back et al. (2006) measured alcohol use 
on a weekly basis and PTSD symptom changes on a monthly basis. This limited the 
ability to investigate the relationship between order of initial symptom improvement 
and to therefore make firm conclusions.  Due to such methodological limitations 
inherent in both of these studies, it is difficult to draw firm conclusions with regard to 
the temporal course of improvement in PTSD and SUD symptoms.  
 
Eight studies reported that individuals with PTSD had higher rates of SUD severity 
(Back et al., 2000; Back et al., 2005; Bornovalova et al., 2009; Clark et al., 2001; 
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Reynolds et al., 2004; Smith et al., 2010; Tull et al., 2010; Villagonzalo et al., 2011) 
compared to those without PTSD.   However, only five of these studies found the 
association between PTSD symptom severity and SUD severity to be statistically 
significant (Bornovalova et al., 2009; Clark et al., 2001; Smith et al., 2010; Tull et al., 
2010; Villagonzalo et al., 2011).  Three of these studies focused on specific 
substances and their relationship to PTSD symptom clusters.  Specifically, 
hyperarousal and avoidance symptoms were found to be significantly associated with 
heroin use (Tull et al., 2010) and crystal methamphetamine (CM) use (Smith et al., 
2010).  Re-experiencing and hyperarousal symptoms were significantly associated 
with cannabis use (Villagonzalo et al., 2011).   
 
Bornovalova et al. (2009) considered the role of emotional regulation whilst 
examining the relationship between PTSD and SUD symptoms.  They found that the 
association between PTSD symptoms and substance use severity was partially 
accounted for by difficulties controlling impulsive behaviour when distressed for 
females and by a lack of emotional awareness and clarity of emotions for males.  It is 
important to highlight that substance use severity was measured by a self-report 
instrument developed by Bornovalova and colleagues.  The investigators failed to 
report the psychometric properties of this measure.  This makes the validity and 
reliability of the reported substance use severity symptoms questionable.           
 
Five of the thirteen studies rated as having „moderate‟ methodological quality 
included a measure of depressive symptoms (Back et al., 2000; Back et al., 2005; 
Clark et al., 2001; Mills et al., 2006; Tull et al., 2010).  A variety of measures were 
employed to capture depression (see Appendix 2, Table 2).  These include the Beck 
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Depression Inventory (BDI), the Composite International Diagnostic Interview 
(CIDI), and the Hamilton Depression Scale (HamD).  In general, individuals with 
PTSD were found to have significantly higher scores on depression measures than 
those without PTSD (Back et al., 2000; Back et al., 2005; Clark et al., 2001; Mills et 
al., 2006).  For one study this finding was only true for male participants (Back et al., 
2005).  For investigations that included a follow-up period (Back et al., 2000; Back et 
al., 2005; Clark et al., 2001; Mills et al., 2006), individuals with PTSD continued to 
demonstrate significantly higher scores for depression compared to those without 
PTSD.  Additionally, Tull and colleagues (2010) found that severity of depression 
was significantly associated with PTSD symptom severity.  
 
Five of the studies examined some form of psychopathology in those with PTSD 
(Back et al., 2000; Clark et al., 2001; Mills et al., 2006; Norman et al., 2007; 
Reynolds et al., 2004).  A broad range of instruments were utilised (see Appendix 2, 
Table 2), including the Brief Symptom Inventory (BSI); Symptom Checklist-90-
Revised (SCL-90-R); and the Composite International Diagnostic Interview (CIDI).  
In line with Driessen and colleagues (2008), there was a trend for those with PTSD to 
have higher rates of psychiatric symptoms and disorders as well as poorer 
psychosocial functioning (Back et al., 2000; Clark et al., 2001; Mills et al., 2006; 
Norman et al., 2007; Reynolds et al., 2004).        
 
Two of the studies rated as having „moderate‟ methodological quality examined 
alexithymia (Evren et al., 2010; Simpson et al., 2006), which was defined as an 
“emotional processing deficit” (Simpson et al., 2006).  Both studies used the Toronto 
Alexithymia Scale-20 to measure this variable.  Results from these studies were not in 
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line with each other.  Evren and colleagues (2010) found that for male alcohol 
dependents, alexithymia, particularly difficulty in identifying feelings, predicted 
PTSD.  On the other hand, Simpson and colleagues (2006) found no relationship 
between alexithymia and PTSD in a largely male alcohol dependent sample.  This 
discrepancy may be due to the differing study designs as well as the variables 
examined and the associated statistical analysis conducted in both studies.  Evren et 
al. (2010) investigated the relationships between PTSD, alexithymia, temperament 
and character dimensions and found associations between all of these variables.  
Simpson et al. (2006) investigated anxiety sensitivity, cognitive avoidance, 
alexithymia and their relationship with PTSD and alcohol use concurrently and 
prospectively.  They found that anxiety sensitivity accounted for a substantial amount 
of variance in PTSD symptom severity.  Cognitive avoidance accounted for additional 
variance.  They also found no significant relationship between alcohol craving/use 
and PTSD symptom severity, anxiety sensitivity and alexithymia.  Use of alcohol 
dependant and largely male participants hinders the generalisability of findings from 
both studies.     
    
3.4 Low Quality 
 
Both Ouimette et al. (2007) and Waldrop et al. (2007) investigated variables 
associated with relapse in those with PTSD compared to those without PTSD.  
Ouimette et al. (2007) found that those with PTSD were more likely to report relapse 
in response to negative emotions than those without PTSD.  Similarly, Waldrop et al. 
(2007) found that those with PTSD reported greater use of cocaine in response to 
negative situations than those without PTSD.  The studies differed in how they 
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measured relapse characteristics.  Ouimette et al. (2007) gathered qualitative data via 
an adapted version of the „relapse interview‟ (Miller and Marlatt, 1996) and Waldrop 
et al. (2007) gathered quantitative data by employing the Inventory of Drug Taking 
Situations (IDTS) (Annis and Martin, 1985).  Additionally, Ouimette et al. (2007) 
followed participants up at six months and found that patients with unremitted PTSD 
reported a more catastrophic view of resuming substance use and lower self-efficacy 
expectations to cope with high-risk situations in the future than those with remitted 
PTSD.  Ouimette et al. (2007) carried out a large number of statistical tests thus 
increasing the likelihood of type one errors. It is important to highlight that the data 
used in Waldrop et al. (2007) study was obtained from two separate studies. 
  
Read and colleagues (2004) investigated PTSD and SUD symptom interplay and the 
impact of PTSD on SUD outcomes by assessing participants at baseline and at six 
months follow-up.  Findings indicated that those with PTSD had more years of 
problem substance abuse but did not differ in terms of current level of substance use.  
Individuals with PTSD were more likely to meet diagnostic criteria for mood and 
other anxiety disorders compared to those without PTSD.  At follow-up, those 
individuals considered to have unremitted PTSD had worse SUD outcomes than those 
with remitted PTSD.  Furthermore, general psychiatric distress at follow-up was 
associated with poorer outcomes.  Such distress was found to mediate the relationship 
between PTSD change status and substance use outcomes.  This study had a          
number of methodological limitations, including omission of exclusion and inclusion 
criteria, minimal description of the sample and no mention of the procedure used.  As 





This systematic review sought to determine the relationship between PTSD and SUD. 
Taking all of the studies together, it would appear that individuals with comorbid 
PTSD and SUD have higher rates of psychiatric disorders; higher scores on 
depression scales; poorer substance use outcomes; emotional regulation and 
processing deficits; are more likely to relapse in response to negative emotions and 
situations; and have negative expectations about being able to cope.  It is not clear 
from the available evidence why those with PTSD have worse clinical profiles than 
those without PTSD.  It is possible that the identified variables, such as depression 
symptoms and difficulties regulating emotions, contribute toward the observed 
relationship between PTSD and SUD.  Understanding the extent to which such co-
occurring variables impact on the association between PTSD and SUD is important as 
they can be targeted by treatment (Clark et al., 2001). 
 
Overall, the results indicate that PTSD and SUD are positively and significantly 
associated.  Specifically, individuals with PTSD, compared to those without PTSD, 
tend to have higher rates of SUD symptoms.  This relationship suggests that 
psychological distress associated with exposure to trauma may be a risk factor for the 
progression of more severe substance use (Clark et al., 2001).  Substance use may 
reduce the negative emotional responses associated with PTSD therefore increasing 
the likelihood of future substance use (Clark et al., 2001).  In line with this 
suggestion, findings indicate that substance abuse and PTSD symptoms increase 
simultaneously (e.g. Clark et al., 2001). 
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Furthermore, there appears to be an association between specific substances and 
PTSD symptoms.  Data from the included studies suggests that individuals with 
PTSD use heroin (Tull et al., 2010) and CM (Smith et al., 2010) to cope with 
hyperarousal and avoidance symptoms and cannabis (Villagonzalo et al., 2011) in 
response to re-experiencing and hyperarousal symptoms.  These substances have 
differing pharmacodynamic properties which makes it difficult to infer that choice of 
substance is motivated by particular PTSD symptoms.  As noted by Villagonzalo et 
al. (2011), the choice of substance use is influenced by factors other than the 
pharmacodynamic properties, such as accessibility and costs.  As such, individuals 
with PTSD may be motivated to use substances to ameliorate or escape PTSD 
symptoms and more broadly, unpleasant emotions (Waldrop et al., 2007) and choice 
of substance use may be influenced by external factors (Villagonzalo et al., 2011).  
However, results do not allow casual inferences to be made regarding particular 
substances and PTSD symptoms.   
 
The relationship between PTSD and SUD is further highlighted by findings that 
demonstrate improvements in substance use following reductions in PTSD symptoms.  
However, there are mixed results regarding the temporal course of improvement of 
symptoms following treatment and methodological issues in a number of the studies 
that prevent firm conclusions being drawn.     
 
Despite some inconsistencies between studies, results of this review appear to be 
broadly in line with the „self-medication hypothesis‟ (Khantizan, 1997).  This theory 
posits that individuals use substances in an attempt to self-treat psychiatric symptoms. 
As related to PTSD, the self-medication theory holds that SUDs may develop 
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following a traumatic event in an attempt to regulate PTSD related negative affect. 
Although results of this review appear to support this hypothesis, it provides a 
minimal explanation regarding the causal mechanisms behind it.  Studies such as 
those by Evren et al. (2010) and Simpson et al. (2006) provide a good starting point in 
the exploration of potential variables that may account for the observed relationship 
between PTSD and SUD.  It would therefore be of interest to explore specifically 
such individual coping styles and or reasons for using substances.   
 
The findings of this review highlight the many methodological flaws that are inherent 
within the literature investigating the association between PTSD and SUD.  The main 
methodological flaws included lack of power calculations, as only one study 
(Reynolds et al., 2004) made any attempt to carry out a power calculation. As such, it 
is difficult to ascertain whether studies had sufficient sample sizes.  This in turn 
makes interpreting findings problematic.  Whilst all of the included studies utilised 
standardised and validated assessment tools, the tools used varied between studies.  
Even when the same instrument was employed across studies, how it was used and 
interpreted differed.  This limits the generalisability of findings.  Heterogeneity of 
research designs results in further difficulties whilst interpreting findings.  
Furthermore, the vast majority of studies included in this review used retrospective 




The methodological quality of studies was assessed using a structured rating scale 
adapted and designed especially for this review. There is a general lack of established 
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methods, which can be used to assess the quality of non-intervention studies 
(Sanderson et al., 2007), and no previously published checklist was found to meet the 
requirements of the review.  As such, quality criteria appraisal methods were based on 
available guidelines and adapted and developed for the purpose of the current review, 
which may impact on the robustness of results. Whilst quality ratings were also 
completed by an independent rater (Z.H) and a high level of agreement was reached, 
there may be limitations in the design of the checklist, which could have introduced 
bias into the ratings.  Furthermore, narrative synthesis is a subjective process (CRD, 
2009) and as such is open to reviewer bias.   
 
Results of the current review must be interpreted with caution and take the limitations 
of the studies reviewed into consideration.  Given the variability of research designs, 
it is difficult to make direct comparison between studies.  The poor generalisability of 
findings between studies must also be held in mind when interpreting results.  These 
issues make it difficult to draw firm conclusions about the relationship between PTSD 
and SUD.   
 
4.2 Conclusions and implications for future research  
 
The findings of this review highlight the complexity of attempting to understand the 
relationship between PTSD and SUD.  It seems safe to say that there is indeed a 
strong relationship between PTSD and SUD.  However, the reasons for this 
association remain unclear.  Given that individuals with PTSD appear to have more 
disturbed clinical profiles and have worse treatment outcomes it seems vital for future 
research to focus on investigating potential causal pathways between these disorders.  
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Identification of possible variables that mediate the relationship between PTSD and 
SUD could allow the development of appropriate interventions.    
 
Bearing in mind the methodological limitations inherent in the research in this area, 
future studies should aim to determine sufficient sample sizes; aim to use prospective 
data; and perhaps make greater use of longitudinal designs to investigate ways in 
which substance use is associated with PTSD. If associations between PTSD and 
SUD are evident after utilising more rigorous methodology this will allow 
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5. Bridging Section 
 
This section provides a brief outline of the objectives and rationale for the current 
empirical study.  
 
Firstly, as the focus of this research portfolio is about comorbid PTSD and SUD 
definitions for both are provided in order to familiarise the reader with these 
disorders. 
 
PTSD develops in some people following the experience or witnessing of an event 
that involves actual or threatened serious injury or death or threat to the physical 
integrity of the self or others (Diagnostic and Statistical Manual of Mental Disorders - 
fourth ed (DSM-IV); American Psychiatric Association (APA), 2000).  Such 
traumatic events are experienced with fear, helplessness, or horror.  The DSM-IV 
diagnosis of PTSD consists of symptoms in three clusters: 1) re-experiencing 
symptoms.  For instance, intrusive thoughts, flashbacks, nightmares and physiological 
responses to reminders of the trauma, 2) avoidance symptoms, which involve reduced 
participation in activities and avoidance of thoughts, people, places, and memories 
associated with the trauma, and 3) hyperarousal symptoms, which include disturbed 
sleeping, irritability, difficulty concentrating, hypervigilance and exaggerated startle 
response.   
 
The DSM-IV classification of a SUD incorporates both substance abuse and 
dependence.  Substance abuse can be defined as the less severe version of the disorder 
and involves a maladaptive pattern of substance use leading to failure to fulfil work, 
school, or home obligations, legal problems, and substance-related interpersonal 
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problems (DSM-IV; APA, 1994). Substance dependence further includes tolerance, 
withdrawal symptoms upon cessation of use, unsuccessful efforts to control use, and 
continued use despite persistent substance-related physical or psychological problems. 
 
5.1 Objective  
 
The objective of the current study was to examine motives for heroin and alcohol use 
in those with PTSD compared to those without PTSD in a treatment-seeking sample 
of adults. 
 
Alcohol and heroin use were focused on in the current study for several reasons.  
Firstly, there is a significantly high prevalence of misuse of alcohol and heroin, in 
comparison to other substances, in the UK and Scotland in particular.  For instance, 
approximately 1.8 per cent of the Scottish population is estimated to misuse opiates 
(Audit Scotland, 2009).  This is almost double the level recorded in England (Audit 
Scotland, 2009). Additionally, Scotland has the highest rate of injecting drug users 
with a rate of 5.6 per 1,000 population compared to 4.2 for the UK as a whole (Audit 
Scotland, 2009). In Scotland, alcohol misuse is even more of a problem than drug use 
in terms of the number of people misusing and the associated health difficulties 
(Audit Scotland, 2009).  For instance, it is estimated that 4.9 per cent of the Scottish 
population is alcohol dependent compared with 3.6 per cent in England (Audit 
Scotland, 2009).  Furthermore, existing evidence suggests that opiates are more 
commonly used by individuals with, than without PTSD (Smith et al. 2010).  
However, there appears to be little research, which has examined the relationship 
between heroin use and PTSD.  
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5.2 Rationale  
 
It has been widely documented that there is a high level of comorbidity between Post 
Traumatic Stress Disorder (PTSD) and substance use disorder (SUD) (e.g. Howard et 
al. 1998).  Research indicates that individuals presenting with comorbid PTSD and 
SUD have worse clinical outcomes (Villagonzalo et al. 2011) and a higher use of 
services (Brown et al. 1995) compared to those presenting with either disorder alone. 
Thus, the high prevalence of co-occurring PTSD and SUD has several important 
implications in terms of service provision and delivery (Najavits, 2002).  Although 
there is an array of literature substantiating the link between PTSD and substance use 
there continues to be a lack of knowledge about the mechanisms underlying this 
association (Dixon et al. 2009).  Such information is pertinent for the development of 
appropriate interventions (Grottfredson & Wilson, 2003) and to thereby reduce the 
high personal and societal costs associated with this comorbidity (Villagonzalo et al. 
2011).   
  
The available research in this area suggests that high rates of comorbidity indicate the 
presence of a functional association between PTSD and SUD (Jacobsen et al. 2001).  
Researchers have proposed several causal pathways that may account for the 
relationship between PTSD and SUD (for a full review see Stewart, 1996; Stewart & 
Concord, 2003).  In one of these pathways, the „high-risk‟ hypothesis, substance use 
is considered to be part of a broad range of „high-risk‟ behaviours, for example 
purchasing illicit substances (Jacobsen et al. 2001).  According to this hypothesis such 
behaviours increase the likelihood of being exposed to traumatic events and 
subsequently developing PTSD (Jacobsen et al. 2001).   
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Alternatively, the „susceptibility‟ hypothesis states that individuals who misuse 
substances are more susceptible to developing PTSD following exposure to a 
traumatic event (Chilcoat & Breslau, 1998). Several mechanisms have been proposed 
to explain why individuals who misuse substances might be more susceptible to 
developing PTSD, including changes in neurochemical systems as the result of 
extensive substance use (Chilcoat & Breslau, 1998).  However, both of these 
hypotheses have received minimal support in the literature (Villagonzalo et al. 2011).  
 
On the other hand, the „self-medication‟ hypothesis posits that individuals with PTSD 
use substances as a means to reduce negative affect (Khantzian, 1997) and emotional 
numbing, which comprise central diagnostic features of PTSD (APA, 2000; 
Khantzian, 1997).  Thus, the hallmark PTSD symptoms of re-experiencing, 
hyperarousal and avoidance may all motivate substance use (Kessler et al. 2005).    
 
The self-medication hypothesis as it relates to PTSD is well supported in the literature 
(Chilcoat & Breslau, 1998).  For instance, a number of studies have demonstrated that 
increases in PTSD symptom severity are associated with increases in substance use 
(e.g. Bornovalova et al. 2009; Clark et al. 2001; Smith et al. 2010; Tull et al. 2010; 
Villagonzalo et al. 2011).  Conversely, improvements in PTSD symptoms have been 
found to be related to reductions in substance use (e.g. Hein et al. 2010; Back et al. 
2006).  Furthermore, several studies have found associations between particular 
substances and PTSD symptom clusters.  For instance, alcohol disorder symptoms are 
related to PTSD arousal symptoms (e.g. Stewart et al.  1998). Hyperarousal and 
avoidance symptoms have been associated with heroin use (Tull et al. 2010) and 
crystal methamphetamine (CM) use (Smith et al. 2010).  Additionally, re-
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experiencing and hyperarousal symptoms have been found to be significantly 
associated with cannabis use (Villagonzalo et al. 2011).  One possibility for such 
associations is that substance use is being motivated by particular PTSD symptoms 
(Smith et al. 2010), which would lend support to the self-medication hypothesis.   
 
Following on from this, one factor that may increase understanding about the 
mechanisms underlying the association between PTSD and SUD is motives for 
substance use (Bujarski et al. 2012).  Research investigating the basic underlying 
motivations for alcohol use suggests that psychological “drinking motives” or reasons 
for drinking serve as a common pathway to alcohol use and abuse (Cooper, 1994; Cox 
& Klinger, 1988).  In this model other variables, such as psychological distress, 
influence misuse of alcohol (Stewart & Devine, 2000).  Cox and Klinger (1988, 1990) 
have proposed a categorical model of alcohol use motives.  In this model, alcohol 
consumption is motivated by a desired outcome on one of two dimensions.  The first 
dimension is referred to as “valence” (positive versus negative).  For instance, alcohol 
is used to obtain a positive outcome or to avoid a negative outcome.  The second 
dimension is “source” (internal versus external).  This dimension involves drinking to 
obtain an internal reward or to gain an external reward, such as social approval (Cox 
& Klinger, 1988, 1990).   
 
These two dimensions yield four distinct categories that relate to drinking motives and 
have been referred to as enhancement, social, coping and conformity motives 
(Cooper, 1994).  Previous research has clearly established the distinctiveness of each 
of the four drinking motives in terms of their validity in predicting unique aspects of 
drinking behavior (see Stewart & Devine, 2000).  Cooper (1994) has developed a 20-
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item self-report measure (Drinking Motives Questionnaire – Revised, DMQ-R) that 
captures the frequency of drinking for these four conceptually and empirically distinct 
reasons.  Although Cooper‟s (1994) measure was designed to examine alcohol use 
motives and has not been validated for use with individuals who use other addictive 
substances, it has been employed to measure marijuana use motives (Bujarski et al. 
2012) and adapted for use with a psychotic population (Spencer et al. 2002).  
Furthermore, there are currently no alternative measures in existence that examine 
motives for substance use other than alcohol.  Additionally, the DMQ-R does not 
appear to capture motives that are unique to alcohol consumption as compared to 
alternative addictive substances.   Therefore, the current study employed this measure 
to capture motives for both alcohol and heroin use.     From a theoretical perspective, 
“using substances to cope” is conceptualised as efforts to escape or avoid negative 
affective states, such as sadness, anxiety, and anger (e.g. Cooper et al. 1988). 
Researchers have suggested that substance use may be used to avoid or reduce the 
symptoms of post traumatic stress following traumatic event exposure, a strategy that 
is negatively reinforcing, thereby maintaining substance use (e.g. Kushner et al. 2000; 
Stewart, 1996; Stewart et al. 1998). 
 
In support of this perspective, evidence suggests that adults may be motivated to use 
substances for coping-related reasons.  These include using substances to cope with 
sleep difficulties (Nishith et al. 2001), to reduce negative affect (Cannon et al. 1992) 
and in response to the symptoms associated with PTSD (Smith et al. 2010; Tull et al. 
2010; Villagonzalo et al. 2011). Additionally, studies investigating perceptions of 
substance use suggest that patients view substances with arousal dampening 
properties to be effective in controlling PTSD symptoms (e.g. Bremner et al. 1996).  
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Other studies have found that patients perceive a causal connection between PTSD 
and substance use (e.g. Clark & Jacob, 1992).  Expectations of substance use have 
also been shown to exert significant influence on substance use behaviour (Schafer & 
Brown, 1991).  In short, expectations and perceptions regarding reduction of PTSD 
symptoms and enhancement of coping may motivate substance use. 
 
Furthermore, several studies have demonstrated significant relationships between 
trauma, PTSD, motives for substance use, alcohol and marijuana consumption, 
depression and anxiety symptoms (Grayson & Nolen-Hoeksema, 2005; Schuck & 
Widom, 2001; Ullman, et al. 2005; Dixon et al. 2009; Bujarski et al. 2012).  Such 
studies have demonstrated that coping motives in particular mediate the relationship 
between psychological distress and substance use (Grayson & Nolen-Hoeksema, 
2005; Schuck & Widom, 2001) and between PTSD and alcohol problems (Ullman et 
al. 2005).  Additionally, PTSD symptoms have been found to be significantly 
associated with coping-related motives for both alcohol (Dixon et al. 2009) and 
marijuana use (Bujarski et al. 2012).  These findings appear to lend support to the 
idea that substance use is aimed at the reduction of PTSD symptoms.  As such, 
motives for substance use appears to be an important factor that can increase 
understanding about trauma related substance use.  However, these relationships have 
only been demonstrated in community and (Grayson & Nolen-Hoeksema, 2005; 
Schuck & Widom, 2001; Ullman et al. 2005) adolescents samples (Dixon et al. 2009; 
Bujarski et al. 2012).  The current study, therefore, sought to add to the array of 
literature investigative the link between PTSD and SUD by comparing motives for 
substance use in a treatment-seeking sample of adults with and without PTSD.   
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A clearer understanding of the dynamic associations between PTSD and SUD may 
shed light on the course of these two disorders, thereby identifying areas for 
intervention which may potentially, reduce some of the associated costly and harmful 
outcomes. It is hoped that the present project will not only complement the existing 
literature regarding comorbid PTSD and SUD but will also shed further light on the 








































6. Aims and hypotheses 
 
The present empirical project aims to examine functional associations between Post 
Traumatic Stress Disorder (PTSD) and substance use disorder (SUD). This will be 
achieved by comparing self-reported motives for substance use amongst adult 
participants who have a history of either alcohol or heroin related SUD and who do or 
do not meet diagnostic criteria for PTSD.   
Based on the existing empirical and theoretical literature the main research 
hypotheses are as follows: 
1. Participants with PTSD will endorse coping-related motives for substance use 
significantly more compared to participants without PTSD (one-tailed) 
2. The remaining self-reported motives (enhancement, social and conformity) for 
substance use will be significantly different for those with PTSD compared to 
those without PTSD (two-tailed) 
3. Substance use severity will be significantly greater for those with PTSD 
compared to those without PTSD (one-tailed) 
The secondary hypotheses are: 
4. Coping-related motives for substance use will be positively associated with 
PTSD symptom clusters (one-tailed).  
5. Anxiety and depression symptoms, as measured by the Hospital Anxiety and 
Depression Scale (HADS) (Zigmond & Snaith, 1983), will be significantly 
higher for those with PTSD compared to those without PTSD (one-tailed) 
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Chapter 3: Empirical Project Methodology 
 
 
Motives for substance use in the presence and absence of Post Traumatic 





















This study employed quantitative methods to answer the research questions.  A 
between-subjects, cross-sectional questionnaire based design was used to examine 
differences between participants with and without Post Traumatic Stress Disorder 
(PTSD) in relation to the following variables: 1) motives for substance use, 2) 
substance use severity, and 3) anxiety and depression scores.  A correlation design 
was used to examine the relationship between motives for substance use and PTSD 
symptom clusters.     
 
7.2 Ethical & design considerations 
 
A number of steps were taken to address ethical and design issues during the planning 
of the study.   
 
7.3 Ethical Approval 
 
The study was reviewed by academic staff at the University of Edinburgh.  The 
research was granted favourable ethical approval by the South East Scotland Research 
Ethics Committee (Appendix 4).  Management approval was obtained from NHS Fife 
Research and Development Team (Appendix 5) and the University of Edinburgh 
acted as the sponsor for this study.   
 
 50 
7.4 Consent   
 
Consideration was given to the possibility of participants viewing failure to 
participate in the study as having the potential to impact on any current or future care.  
This concern was highlighted to the relevant staff members who would be providing 
information sheets to potential participants.  When staff members asked their clients if 
they wished to participate in the study, it was made explicit that participation was 
entirely voluntary and that they were under no obligation to take part.  It was also 
made explicit that if they agreed to take part in the study, they could withdraw at any 
point.  The researcher also discussed these points with participants at the initial point 
of contact. The voluntary nature of the study was also made clear in the Patient 
Information Sheet (PIS). 
 
7.5 Anxiety and Depression 
 
The possibility of excluding participants without PTSD who had symptoms 
suggestive of anxiety and/or depression was considered.  However, it was decided that 
this would not be appropriate for the current study given the prevalence of comorbid 
anxiety and mood disorders among the substance abusing population (Merikangas et 
al. 1998; Grant et al. 2004).  In turn, the present study aimed to capture a realistic 
clinical sample of participants accessing Addiction Services.  Therefore, inclusion of 
participants with symptoms of anxiety and/or depression was deemed appropriate.  
Additionally, excluding participants with anxiety and/or depression could have 
resulted in a significantly lower amount of usable data.   In turn, this would have had 
the potential to impact on the power of the study, thereby increasing the risk of 
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making a type two error.  The Hospital Anxiety and Depression Scale was selected to 
capture all of the participant‟s anxiety and/or depression symptoms.  This allows for 
reporting of potential confounding factors and to control for this in the analysis if 
necessary.   
 
7.6 Duty of Care 
 
Given the nature of the study, consideration was given to the potential for participants 
to become distressed whilst responding to the questionnaires.  It was decided that the 
researcher had a responsibility or duty of care to respond to participants who 
presented as highly distressed.  Responses to distressed patients involved: 
 
 The option to either have a break or completely withdraw from the study  
 Referral to an appropriate service (in agreement with the participant) 
 Provision of self-help materials 
 
This procedure was highlighted prior to participation in the study as well as in the 
PIS.  Additionally, the PIS and consent form stated that if participants indicated the 
intention to harm themselves (or others) that their GP and other relevant professionals 
would be informed.  Again, this was made explicit by the researcher prior to consent 






7.8 Informing GP’s about Participation  
 
The possibility of routinely informing participants GP‟s about involvement in the 
study via a standard letter was considered.  However, it was decided that this was not 
appropriate and may have acted as a barrier to participation in the study for many 
patients.  That is, for many of the potential participants, their GP‟s may not be aware 




The sample comprised of two groups of participants.  Group one included individuals 
who met diagnostic criteria for Post Traumatic Stress Disorder (PTSD) and a 
substance use disorder (SUD).  Group two included participants who met diagnostic 
criteria for a SUD only.  Participants were recruited from the various Addiction 
Services available in the local area.  These included, Addictions Clinical Psychology, 
a community rehabilitation service, a drug and alcohol counselling service, an alcohol 
counselling service, and a prescribing service (NHS Addictions Service).  Participants 
were included in the study if they had used either alcohol or heroin in the past 12 
months and if they were aged between 18 and 65 years.  All participants spoke 
English and met diagnostic criteria for a SUD.  Participants were excluded from 
participation in the study if they had an identified cognitive impairment, learning 
disability or major psychiatric diagnosis (e.g. bipolar affective disorder or 
schizophrenia).  This was confirmed by checking with the referring professional. 
Additionally, participants were excluded if they had a history of trauma but did not 
meet diagnostic criteria for PTSD.    
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A total of 86 participants indicated interest in taking part in the study, 14 of which did 




A copy of all materials used in the current study can be found in Appendix six.  
Materials included the PIS, consent form, a demographic information sheet, a 
structured diagnostic interview and nine questionnaires, specifically: The Mini 
International Neuropsychiatric Interview (MINI), The Trauma History Questionnaire 
(THQ), the Impact of Events Scale – Revised (IES-R), The Addiction Severity Index 
(ASI), The Michigan Alcoholism Screening Test (MAST), The Drug Abuse 
Screening Test - 20 (DAST), The Drinking Motives Questionnaire-Revised (DMQ-
R), The Heroin Motives Questionnaire-Revised (HMQR) and the Hospital Anxiety 
and Depression Scale (HADS).  Each of these measures will be discussed in turn.  
 
9.1 Patient Information Sheet (PIS) 
 
A PIS was developed in order to provide details about the purpose and nature of the 
study, how and where data would be stored, and how it would be used.  It was made 
clear to particpants that current and future service provison would not be affected in 
any way by choosing to take part or not in the study.  It was also highlighted that the 
study aimed to gather information about particpants who had and had not experienced 
a history of trauma.  Additionally, details were provided of what is meant by this.  
The risks to particpants were explained and contact details were provided for 
particpants who had any questions or concerns.  Particpants were also informed that 
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their responses would be anonoymous and that data would be stored in a locked filling 
cabinet on secure NHS premises.   
 
9.2 Consent Form 
 
A consent form was produced in line with guidance supplied by the South East 
Scotland Research Ethics Committee and NHS Fife Research and Development 
department.  
 
9.3 Demographic Information Sheet 
 
A demographic information sheet was designed to collect data regarding gender, age, 
relationship status, employment status and ethnicity.  This was designed in order to 
collect information regarding the demographic characteristics of the sample. 
 
9.4 The Mini International Neuropsychiatric Interview (MINI) (Sheehan et al. 1998) 
 
The MINI is a short structured diagnostic interview designed for use in clinical and 
research settings (Sheehan et al. 1998).  It was developed to assess the diagnoses of 
17 psychiatric disorders according to DSM-IV and/or ICD-10 criteria.  It is fully 
structured to allow administartion by non-specialised interviewers (Sheehan et al. 
1998). In order to keep it short, it focuses on the existence of current disorders.  For 
each disorder, one or two screening questions rule out the diagnosis when answered 
negatively.  The MINI is a brief and patient friendly measure (Vliet & Beurs, 2007).  
It takes considerably less time to complete in comparison to the alternative diagnostic 
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interviews (Pinninti et al. 2003) such as, the Structured Clinical Interview for DSM-
IV disorders (SCID), the Composite International Diagnostic Interview (CIDI) or the 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN).   
 
The MINI has been validated in the USA and Europe and is available in twenty 
languages.  There have been several studies conducted which investigate the 
psychometric properties of the MINI (e.g. Sheehan et al. 1997, Lecrubier et al. 1997).  
Overall, such studies indicate that the MINI is a reliable and valid instrument in terms 
of eliciting symptom criteria used in making DSM-IV and ICD-10 diagnoses 
(Sheehan et al. 1998). Furthermore, the positive psychometric properties of the MINI 
have been said to make it an appropriate choice for research purposes (Vliet & Beurs, 
2007).   
 
The PTSD and SUD modules were used for the purpose of the current study to 
establish the presence or absence of PTSD and SUD.  This measure was utilised due 
to its demonstrated psychometric properties, its efficient administration time and in 
order to overcome some of the methodological limitations identified in the existing 
literature. Namely, many studies lack information regarding whether participants meet 
the criteria for a current diagnoses of PTSD and SUD.  
 
9.5 Trauma History Questionnaire (THQ) (Green, 1996).  
 
The THQ is a 24-item self-report measure that gathers data about a person‟s lifetime 
history of exposure to traumatic events in three categories:  crime, general disaster 
and trauma and, sexual/physical assault experiences.  The respondent indicates, 
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whether or not they have ever had the experience (yes/no), and if yes, the number of 
times and the age of occurrence.  For the sexual and physical assault items, 
participants indicate whether they have had the experience (yes/no), whether it was 
repeated, and if yes, how often and at what age(s).  Additionally, the THQ includes a 
final item, which allows respondents to report experiences that they considered 
extremely stressful, regardless of whether these events would be considered traumatic 
by the investigators.  This item can also identify traumatic experiences that are more 
appropriately recorded elsewhere.  In this latter case, the item is re-scored in the 
appropriate category.  Otherwise, the item is not scored.  As the THQ is a history-
gathering instrument, there is no standard way of scoring or interpreting results 
(Green, 1996).   
 
The THQ is based on the high magnitude stressor interview from the DSM-IV PTSD 
field trails (Kilpatrick & Resnick, 1992), and has been used with several clinical and 
non-clinical samples.  It has good test-retest reliability over a two to three month 
period and produces significant correlations with self-reported distress in college 
students (Green et al. 1996) and with measures of distress and functional status in 
clinical patients (Green et al. 2000).  Total and subscale scores have also been found 
to predict PTSD in cocaine-dependent outpatients (Najavits et al. 1998). 
 
The current study employed the THQ for several reasons.  Firstly, this measure has 
been frequently used to investigate trauma prevalence in substance abusing samples.  
Secondly, to clarify the specific nature of participant‟s trauma experience, preparatory 
to a diagnostic interview and symptom checklist for PTSD.  Lastly, in order to 
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minimise confounding variables, the THQ was used to establish a group of substance 
abusing participants who have no trauma histories.   
 
9.6 The Impact of Event Scale - Revised (IES-R) (Weiss & Marmar, 1996) 
 
The IES-R assesses self-reported PTSD symptomatology experienced in the past 
seven days, and consists of 22 items measured on a five-point Likert scale (0-4, with 
labels of „not at all‟ to „extremely‟).  The revised edition was developed in order to 
incorporate 7 additional items related to the hyperarousal symptoms of PTSD, which 
were not included in the original IES.  As such the IES-R items correspond directly to 
14 of the 17 DSM-IV symptoms of PTSD.  The IES-R yields a total score (ranging 
from 0 to 88) and subscale scores can also be calculated for the re-experiencing (8 
items), avoidance (8 items), and hyperarousal (6 items) subscales.   The authors 
recommend using means instead of raw sums for each of these subscales scores to 
allow comparison with scores from the Symptom Checklist 90 – Revised (SCL-90-R; 
Derogatis, 1994).  
 
The three symptom subscales of the IES-R have been shown to reliably identify 
substance dependant individuals with and without PTSD (Rash et al.  2008).  The 
IES-R has also been demonstrated to have high internal consistency among the total 
and subscale scores, as well as excellent reliability and construct validity in a 
substance abusing sample (Rash et al. 2008).  In general, the IES-R is not intended as 
a diagnostic instrument however, it is commonly employed as a screening measure to 
assess the presence and severity of PTSD symptoms.    
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The IES-R was selected due to its demonstrated reliability and validity with substance 
abusing individuals (Rash et al. 2008).  Additionally, severity of PTSD symptoms can 
be identified.   
 
9.7 The Addiction Severity Index (ASI) 5
th
 Edition (McLellan et al. 1992) 
 
The ASI is one of the most widely used assessment instruments in the substance abuse 
field (Alterman et al. 1998).  It has been used by numerous researchers in studies of 
treatment outcomes and as a clinical assessment tool in thousands of treatment 
facilities (McLellan et al. 1992).  The ASI is a semi-structured interview, which 
gathers information about the severity of seven potential problem areas (medical 
status, employment and support, drug and alcohol use, legal status, family/social 
relationships, and psychiatric problems) commonly affected by drug and alcohol 
dependence.  The ASI gathers information relating to recent (past 30 days) and 
lifetime problems in each of the seven problem areas. The ASI provides two scores.  
First, severity ratings which are subjective ratings of the client‟s need for treatment 
derived by the interviewer. Secondly, composite scores which are measures of 
problem severity during the prior 30 days. The ASI has been used with psychiatrically 
ill, homeless, pregnant, and prisoner populations, but its major use has been with 
adults seeking treatment for substance abuse problems (Alterman et al. 1998). 
 
The inter-rater reliability of the composite scores for the ASI has been reported as 
excellent (Alterman et al. 1998) and high for the interviewer severity ratings 
(McLellan et al. 1985).  The internal consistency of the ASI has been reported as 
being satisfactory (Alterman et al. 1998).    
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The authors of the ASI have indicated that it is acceptable to eliminate entire sections 
of the interview to meet the needs of a particular research question (McLellan et al. 
1992).  For the present study, only the questions regarding alcohol/drug use status 
were incorporated to provide a measure of SUD severity.  This section asks 
participant‟s to rate how important they currently regard treatment for their substance 
use (0-4, with labels of „not at all‟ to „extremely‟), how troubled they have been in the 
past 30 days by their substance use (0-4, with labels of „not at all‟ to „extremely‟) and 
their age of onset of substance use. 
 
The ASI was selected for use in this way in the current study due to the lack of 
measures that provide an indication of SUD severity.  The other sections of the ASI 
were not deemed to be appropriate or necessary in terms of the research question.  
Furthermore, the ASI was selected given its extensive use in clinical and research 
settings and the demonstrated psychometric properties.   
 
9.8 The Michigan Alcoholism Screening Test (MAST) (Selzer, 1971) 
 
The MAST was developed as a quick self-report screening instrument that focuses on 
alcohol use in the past 12 months and consists of items with a yes/no format.  Over 
the years, several variations of the MAST have been developed, including the brief 
MAST, the short MAST, as well as the self-administered MAST. The current study 
utilised the 22-item version of the MAST.  Skinner (1979), reports that the total score 
yielded by the MAST is useful in classifying patients along a continuum according to 
degree of alcohol misuse.   Effectively, the MAST is useful for assessing the severity 
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of alcohol problems (Saltstone et al. 1994).  The total score is computed by summing 
all items that are endorsed in the direction of increased alcohol problems and indicates 
the problem level associated with alcohol misuse.  (e.g. a total score between 6-10 
indicates „intermediate‟ problem level; 11-15 indicates a „substantial‟ problem and 
scores between 16-22 indicated the presence of a „severe‟ problem). 
 
The MAST has been demonstrated as being a valid instrument with substantial 
correlations between scores on the MAST and scores on other alcohol-use scales 
having been reported (Ross et al.  1990). Furthermore, Zung (1978) reported that the 
instrument has adequate reliability and validity in its original, abbreviated and self-
administered forms.  It has been used effectively with both hospitalised and non-
hospitalised populations (Zung, 1978) and has been used widely in both clinical and 
research settings (Gibbs, 1983).   
 
The MAST was selected for use in the present study due to the ability to classify level 
of severity of alcohol misuse. As such, the MAST provides a further measure of 
severity of SUD.   
 
9.9 The Drug Abuse Screening Test - 20 (DAST) (Skinner, 1982) 
 
The DAST-20 consists of 20 items with responses taking the form of yes/no.  It 
focuses on drug use within the past 12 months.  The DAST yields a quantitative index 
of the extent of problems related to drug abuse. Thus, it allows the reseracher to 
record a reliable estimate of the degree of problem severity.  The total score is 
computed by summing all items that are endorsed in the direction of increased drug 
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problems and indicates the problem level associated with substance use (e.g. a total 
score between 6-10 indicates „intermediate‟ problem level; 11-15 indicates a 
„substantial‟ problem and scores between 16-20 indicated the presence of a „severe‟ 
problem). 
 
The DAST was designed to be used in a variety of settings to provide a quick index of 
drug-related problems.  The 20-item DAST has been demonstarted as having 
excellent internal consistency and reliability with a drug abusing population (Skinner, 
1982).   Subsequent research has evaluated the DAST with various populations and in 
a variety of settings including psychiatric patients (Cocco & Carey, 1998; Maisto et 
al. 2000; Staley & El Guebaly, 1990), prison inmates (Peters et al. 2000), substance-
abuse patients (Gavin et al. 1989), primary care (Maly, 1993), in the workplace (El-
Bassel et al. 1997), and adapted for use with adolescents (Martino et al. 2000). 
Overall, these studies support the reliability and diagnostic validity of the DAST in 
diverse contexts. 
 
The DAST-20 was selected for use in the present study due to its ability to classify 
level of severity of drug use. As such, the DAST-20 provides a further measure of 
severity of SUD.   
 
9.9.1 The Drinking Motives Questionnaire-Revised (DMQ-R) (Cooper, 1994) 
 
The DMQ-R contains 20 reasons why people might be motivated to drink alcoholic 
beverages. Participants rate on a 5-point scale how frequently each of the 20 listed 
reasons motivate them to drink alcoholic beverages. The measure yields four scale 
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scores reflecting different motives for drinking alcohol - enhancement, social, coping, 
and conformity motives.  The DMQ-R demonstrates good structural and criterion 
validity, as well as internal consistency, with alphas for each subscale ranging from 
0.81 to 0.94 (Maclean & Lecci, 2000). 
 
The current study employed this measure based on the available literature surrounding 
the reasons for alcohol use.  Drinking motives or reasons for drinking have been 
posited to comprise the “final common pathway to alcohol use” through which other 
influences on drinking behaviours operate (Cox & Klinger, 1990).  The internal, 
affect-regulation motives, as measured by the DMQ-R have been found to be 
concurrently associated with riskier alcohol use (Dixon et al. 2009).  Furthermore, 
Cooper (1994) stipulates that enhancement and coping motives are both positively 
related to typical frequency and quantity of alcohol consumption, heavy drinking and 
alcohol problems.    This questionnaire was therefore selected for use in the current 
study to measure participant‟s motives for alcohol use.  Furthermore, to the author‟s 
knowledge, there are no alternative measures that examine motives for alcohol use. 
 
This measure is typically used to investigate lifetime motives for alcohol use.  In the 
present study, the DMQ-R focused on motives for alcohol use in the past 12 months.  
The purpose of this was to increase the likelihood of capturing a specific time frame 
for motives of alcohol use and also to align the time frame captured by the other 





9.9.2 The Heroin Motives Questionnaire-Revised (HMQ-R) 
 
The only available instruments that measure motives for substance use other than 
alcohol include one that focuses on cannabis use (Bujarski et al. 2012) and one that 
has been adapted for use with a psychotic population (Spencer et al. 2002).  Both of 
these instruments are adaptations of the DMQ-R and are not applicable for use in the 
current study.  As such, in order to assess motives for using heroin, the DMQ-R was 
modified, changing „alcohol‟ to „heroin‟.  It was decided to use Cooper‟s (1994) 
measure in this way to broaden the nature of the current investigation to include those 
that misuse heroin.  This was deemed appropriate given that the DMQ-R captures 
motives that do not appear to be unique to alcohol compared to other substances of 
choice.  Effectively, the HMQ-R yields the same four subscales as the DMQ-R.   
 
Again, participants were asked to think about their motives for using heroin in the 
past 12 months.   
 
9.9.3 The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983). 
 
The HADS is a 14 item self-report questionnaire that consists of seven items for 
anxiety and seven for depression.  The items are scored on a four-point scale ranging 
from zero (not present) to three (considerable).  Response choices vary by item, but 
higher numbers reflect increasing severity of symptoms.  Item scores are added, 
giving sub-scale scores for anxiety and depression, ranging from zero to 21.  
Although the HADS was designed for use with hospital General Medical Outpatients, 
it has been extensively used in Primary Care (Bjelland et al. 2002).  The 
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recommended cut-offs for use with adults in primary care settings are eight for both 
depression and anxiety (Olsson et al. 2005). 
 
The concurrent validity of the HADS compared to other questionnaires for anxiety 
and depression is reported as being between 0.60 and 0.80 for both sub-scales 
(Bjelland et al. 2002).  The internal consistency of the HADS has been reported to be 
good (Bjelland et al. 2002).  Additionally, the reported severity of symptoms assessed 
using the HADS and psychiatric ratings have been demonstrated to be significantly 
correlated (Zigmond & Snaith, 1983).  As such, the HADS is considered to be a valid 
and reliable assessment of mood disorder presence and severity. 
 
In the present study, this measure was incorporated to screen for symptoms of anxiety 
and depression in all participants.  This was decided based on the available literature, 
which reports a high prevalence of anxiety and depression in the SUD population (e.g. 
Grant et al. 2004; Merikangas et al. 1998).  Furthermore, PTSD patients typically 
report higher levels of anxiety and depression than non-PTSD patients (Schafer & 
Najavits, 2007). Thus, it is important to identify anxiety and depression levels in both 
the PTSD group and the SUD only group to reduce confounding and to increase the 




Data used in this study were collected via questionnaires.  Additionally, demographic 
information was recorded by the researcher on a pre-designed data collection sheet.  
Approval for the study was sought and secured from the South East Scotland 
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Research Ethics Committee and NHS Fife Research and Development Team. 
Guidance from the University of Edinburgh was also supplied.  The researcher 
attended the various Addiction Services „team meetings‟ to inform staff about the 
purpose and nature of the project.    Staff members from each service were provided 
with a batch of Patient Information Sheets to disseminate to their clients.  Potential 
participants were given at least a one-week period to consider whether or not they 
would like to participate in the current study.  Clients who indicated that they would 
like to take part informed their „worker‟ and provided verbal consent for their name 
and telephone number to be passed on to the researcher.  Upon receipt of names and 
telephone numbers, the researcher contacted each potential participant and suitable 
interview locations and times were arranged.  Interviews were conducted in various 
secure clinic spaces throughout the local area.  At the interview, consent was taken 
after the researcher was satisfied that each participant fully understood that 
participation was optional and what was involved.  After consent was taken the 
researcher then administered the questionnaires.  Participants who had no history of 
trauma exposure, as indicated by the THQ, were not administered the PTSD 
measures.  Apart from this, all participants were administered the relevant 
questionnaires.  Participants who indicated experiencing multiple traumas were asked 
to identify, where possible, the trauma that they felt was the most distressing and had 
the worst impact on them overall.  The most traumatic event, again where possible, 
was then considered whilst completing the IES-R.  Data from completed 
questionnaires were entered into a Statistical Package for Social Science (SPSS) 
spreadsheet and analysed accordingly.  Responses to questionnaires were anonymous 
such that no participant could be matched to their responses.  Consent forms were 
stored separately from questionnaire responses to ensure anonymity.  Both consent 
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forms and completed questionnaires were stored in a locked cabinet that only the 
researcher had access to.      
 
11.  Power calculation & sample size  
 
Sample size was determined according to the procedures required when between 
groups analysis is to be applied to data (Clark-Carter, 2010).   Unfortunately, no 
relevant effect sizes are reported in the literature to allow estimation of the effect size 
for the present study.  As such, it was decided to determine the number of participants 
required to achieve a medium effect size of 0.6 with alpha set at 0.05 (Clark-Carter, 
2010).  Considering this it was estimated that in order to test the main hypothesis, 35 
participants per group would be required to achieve power of 0.80 (Clark-Carter, 
2010).   Thus, the total estimated sample size required would be 70 participants.  A 
further sample size calculation was carried out using „GPOWER‟ version 2, which is 
a statistical package used to calculate sample size (Erdfelder et al. 1996).  This 
calculation, based on the same criteria, indicated that a sample size of 36 participants 
per group was required for between groups analysis.  The upper limit was selected for 
the current study.        
 
12. Statistical analyses 
 
All analyses were performed using the Statistical Package for Social Science (SPSS) 
for windows version 18.   Prior to beginning analyses, tests of normality of 
distribution and homogeneity of variance were conducted to evaluate the data against 
assumptions for parametric tests (Clark-Carter, 2010).  The assumptions of parametric 
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data were tested for those with and without PTSD (regardless of SUD type) and by 
SUD type (alcohol versus heroin, regardless of PTSD status) (See Chapter 5, extended 
results).  An alpha (p) level of 0.05 was used for all analyses.  
 
 Histograms, Q-Q plots and, the Kolmogorov-Smirnov test were used to determine if 
the distribution of scores differed significantly from normality.  If the Kolmogorov-
Smirnov test (D) is significant (p < 0.05), data are said to have significantly non-
normal distributions.  Homogeneity of variance was assessed using Levene‟s test.  If 
Levene‟s test is significant (p < 0.05), this indicates that the assumption of equal 
variances has been violated. If this assumption is violated, it can be corrected by 
reporting the test statistic that does not assume equal variances (Welch‟s t-test).     
 
Parametric tests were selected, as they are more powerful statistics (Clark-Carter, 
2010).  When the assumptions of parametric tests were violated the non-parametric 
equivalents were also carried out.  This was to establish if the results were in line with 
the parametric finding and to reduce the likelihood of committing a type one error.  
Unless otherwise specified, the results of the non-parametric tests were in line with 
the parametric results. 
  
The sample characteristics were explored to provide additional information about the 
research sample.   Descriptive statistics were presented for the demographic and 
clinical variables.  The data were then examined in relation to the research hypotheses 
(see Chapter 4): 
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Hypothesis 1 compared scores on the coping-related motives for substance use 
subscale for those with and without PTSD.  Data were explored through the use of an 
independent samples t-test (one-tailed). 
 
Hypothesis 2 compared scores on the remaining motives (enhancement, social and 
conformity) for substance use subscales for those with PTSD and without PTSD. Data 
were explored through the use of an independent samples t-test for each of these 
subscales (two-tailed).     
 
Hypothesis 3 compared substance use severity for those with and without PTSD.  
Data were analysed with use of a chi-square test (one-tailed). 
 
Hypothesis 4 explored the relationship between the coping-related motives subscale 
and PTSD symptom clusters.  This relationship was analysed through the use of 
Pearson‟s correlation (one-tailed).  
 
Hypothesis 5 compared anxiety and depression scores for those with and without 
PTSD.  This hypothesis was investigated by use of an independent t-test (one-tailed).   
 
As noted, non-parametric equivalents (e.g. Mann-Whitney U/Spearman‟s correlation) 
were also carried out when assumptions of parametric testing were violated.   
 
Additional exploratory analyses were undertaken to examine the relationships 
between PTSD status, specific substance use (alcohol versus heroin), motives for 
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substance use, severity of substance use, anxiety and depression scores, PTSD 
symptom clusters (Chapter 5, extended results). 
 
Effect sizes were calculated for significant findings.  For t-tests the following 
calculation was used, d = Mgroup1 – Mgroup2 / SD pooled (Clark-Carter, 2010).  
Cohen‟s (1992) guidance was used to determine the size of significant findings for d 
(e.g. small = 0.2, medium = 0.5, large = 0.8) 
 
The following calculation was used to determine effect sizes for Mann-Whitney U 
tests, r = Z /√N (Clark-Carter, 2010; Field, 2005).  Again, Cohen‟s (1992) guidance 
was used to determine the size of significant findings for r (e.g. small = 0.1, medium 
0.3, large = 0.5). 
 
For the chi-square tests the Odds Ratio (OR) was calculated as follows; n11 x n22  / n12  x 
n21 (Clark-Carter, 2010).   
 
The internal reliability of the DMQ-R and the HMQ-R measures were assessed using 
Cronbach‟s alpha.  The internal reliability was assessed by SUD group (alcohol 
versus heroin) for all participants and separately for the PTSD and no-PTSD groups.  
Items identified as having a corrected item-total correlation of 0.4 or below and that 
were significantly reducing Cronbach‟s alpha were removed.  Analyses were 





Chapter 4: Journal Article  
 
Motives for substance use in the presence and absence of Post Traumatic 
Stress Disorder (PTSD) 
 
Isabel Traynor 





Dr Zoe Hughes 





Dr Andrew Summers  




Professor Mick Power 










This article has been written in accordance with Drug & Alcohol 
Dependence author guidelines (Appendix 1) 
 71 






Background Post Traumatic Stress Disorder (PTSD) is frequently linked with 
substance use disorder (SUD).  However, the nature of this association remains 
unclear.   
 
Objective The main objective of the current study was to explore functional 
associations between PTSD and SUD. This was achieved by comparing motives for 
substance use, SUD symptom severity, and anxiety and depression symptoms 
amongst treatment-seeking adults with and without PTSD.   
 
Method This is a between subjects, cross-sectional questionnaire based study.   
 
Results Participants with PTSD endorsed coping-related motives for substance use 
significantly more, had elevated substance use severity profiles, and higher levels of 
anxiety and depression, than participants without PTSD  
 
Conclusions Findings lend support to the self-medication hypothesis suggesting that 






Keywords: Post Traumatic Stress Disorder; Substance Use Disorder; Comorbidity; 
substance use motives.   
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13. Introduction  
 
It has been widely documented that there is a high level of comorbidity between Post 
Traumatic Stress Disorder (PTSD) and substance use disorder (SUD) (e.g. Howard et 
al., 1998; Jacobsen et al., 2001).  Research indicates that individuals presenting with 
comorbid PTSD and SUD have worse clinical outcomes (Villagonzalo et al., 2011), 
elevated rates of psychiatric symptoms, and a higher use of services (Brown et al., 
1995) compared to those presenting with either disorder alone. Thus, the high 
prevalence of co-occurring PTSD and SUD has several important implications in 
terms of service provision and delivery (Najavits, 2002).  Although there is an array 
of literature substantiating the link between PTSD and SUD there continues to be a 
lack of knowledge about the mechanisms underlying this association (Dixon et al., 
2009).  Such information is pertinent for the development of appropriate interventions 
(Grottfredson and Wilson, 2003), and to thereby reduce the high personal and societal 
costs associated with this comorbidity (Villagonzalo et al., 2011).   
 
Several theories have been proposed in an attempt to understand the nature of the 
relationship between PTSD and SUD (see Chapter 2).  Research lends the most 
support to the idea that substance use may function as a method to reduce 
psychological distress (Khantizan, 1997).  This model, as it relates to PTSD, views 
substance use as an attempt to cope with distressing post traumatic stress symptoms 
and has been substantiated by a number of studies (Chilcoat and Breslau, 1998).  For 
instance, evidence suggests that increases in PTSD symptoms often lead to elevated 
levels of substance use (Villagonzalo et al., 2011).  Conversely, improvements in 
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PTSD symptoms are related to reductions in substance use (Back et al., 2006; Hein et 
al., 2010).   
 
The examination of what motivates substance use is one promising approach that may 
increase understanding about the association between PTSD and SUD (Bujarski et al., 
2012).  Four motives are conceptualized to be involved in substance use behavior 
(Cooper, 1994).  These include coping (e.g. to reduce internal negative affective 
states), conformity (e.g. to reduce external negative social outcomes), enhancement 
(e.g. to increase internal positive states), and social motives (e.g. to increase positive 
external outcomes) (Cooper, 1994).  
 
From the available literature with community and adolescent samples it is apparent 
that substance use is consistently linked with coping-related motives (e.g. Nishith et 
al., 2001; Dixon et al., 2009; Bujarski et al., 2012).  From a theoretical perspective, 
“using substances to cope” is conceptualised as efforts to escape or avoid negative 
affective states, such as sadness, anxiety, and anger (e.g., Cooper et al., 1988).  
Empirical data demonstrate that substances may be used to cope with core PTSD 
symptoms (e.g. re-experiencing, avoidance, and hyperarousal) (Smith et al., 2010; 
Tull et al., 2010; Villagonzalo et al., 2011), general negative affect (Cannon et al., 
1992), and sleep difficulties (Nishith et al., 2001)   
 
Such findings appear to lend support to the „self-medication‟ hypothesis, suggesting 
that individuals with PTSD may use substances to cope with negative affect in the 
context of posttraumatic stress symptoms (Khantizan, 1997).  However, there is 
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limited evidence from adult clinical samples examining motives for substance use in 
the presence of PTSD.   
 
The current study sought to address this limitation, as well as contribute a novel 
extension to the existing research, by examining motives for alcohol and heroin use 
amongst a treatment-seeking sample of adults with and without PTSD. It was 
hypothesised that participants with PTSD would endorse coping-related motives for 
substance use significantly more than participants without PTSD.  It was also 
anticipated that there would be significant differences between the PTSD and no-
PTSD group for scores on the enhancement, social and conformity motives for 
substance use subscales.  Substance use severity, anxiety and depression scores were 
also expected to be significantly higher for participants with PTSD compared to those 
without. Additionally, it was predicted that coping-related motives for substance use 
would be positively associated with PTSD symptoms (see Chapter 2, section 6 for 




A detailed description of the methods used to conduct the present study is presented in 
Chapter three.  
 
This is a cross-sectional study, which compared a sample of patients with comorbid 
SUD and PTSD to a sample with SUD without PTSD.  The research was approved by 
the South East of Scotland Research Ethics Committee (Appendix 4) and NHS Fife 





The total (N = 72) sample comprised of two groups of 36 participants.  Group one 
included individuals who met diagnostic criteria for PTSD and a SUD.  Group two 
included participants who met diagnostic criteria for a SUD only.  Participants were 
recruited from the various Addiction Services available in the local area.  These 
included Addictions Clinical Psychology, a community rehabilitation service, a drug 
and alcohol counselling service, an alcohol counselling service, and a prescribing 
service (NHS Addictions Service).  Participants were included in the study if they had 
used either alcohol or heroin in the past 12 months (N = 2 did not meet this inclusion 
criteria) and if they were aged between 18 and 65 years.  All participants spoke 
English and met diagnostic criteria for a SUD.  Participants were excluded from 
participation in the study if they had an identified cognitive impairment (N = 3), 
learning disability or major psychiatric diagnosis (e.g. bipolar affective disorder or 
schizophrenia).  This was confirmed by checking with the referring professional.  
Participants were excluded if they met diagnostic criteria for a SUD relating to a 
substance other than alcohol or heroin (N = 2).  Additionally, participants were 
excluded if they had a history of trauma but did not meet diagnostic criteria for PTSD 











The psychometric properties of the measures used in the current study are presented 
in Chapter three, section nine. 
  
Demographic details were obtained from all participants.  Trauma exposure, PTSD, 
SUD and associated problems, motives for substance use, anxiety and depression 
scores were assessed using standardised measures and questionnaires as described 
below:  
 
The Trauma History Questionnaire (THQ; Green, 1996) consists of 24 items 
addressing a range of trauma events in three areas: 1) crime-related events, 2) general 
disaster and trauma, and 3) unwanted physical and sexual experiences.  Respondents 
indicate whether they have experienced this event, how many times this has 
happened, and age of occurrence.  For the sexual/physical experiences category, they 
also identified whether experiences were repeated and how often.  The THQ was used 
to differentiate a group of participants without trauma histories.  For those with 
trauma histories it also served to clarify the specific nature of each participant‟s 
trauma experience, and was followed by completing a diagnostic interview and 
symptom checklist for PTSD.    
 
Participants who indicated experiencing multiple traumas were asked to identify, 
where possible, the trauma that they felt was the most distressing and had the worst 
impact on them overall.  The most traumatic event, again where possible, was then 
considered whilst completing the PTSD measures.   
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The Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998) is a 
short structured diagnostic interview designed for use in clinical and research settings.  
It assesses the diagnoses of 17 psychiatric disorders according to DSM-IV and/or 
ICD-10 criteria.  The PTSD and SUD modules were used to establish the presence or 
absence of PTSD and SUD.  The PTSD module was only administered to participants 
who indicated a history of trauma.   
 
The Impact of Event Scale - Revised (IES-R; Weiss and Marmar, 1996) consists of 22 
items measured on a five-point Likert scale (0-4, with labels of „not at all‟ to 
„extremely‟) and measures PTSD symptomatology experienced in the past seven 
days.  Items are grouped into PTSD symptom clusters as described in the DSM-IV: 
re-experiencing (8 items), avoidance (8 items), and hyperarousal (6 items). This 
instrument was utilised to assess the severity of symptom clusters in the PTSD group.   
 
The Michigan Alcoholism Screening Test (MAST; Selzer, 1971) & The Drug Abuse 
Screening Test - 20 (DAST; Skinner, 1982) measures focus on alcohol and drug use 
respectively within the past 12 months. Responses take the form of yes/no and yield a 
quantitative index of the extent of problems related to substance abuse.  The total 
score is computed by summing all items that are endorsed in the direction of increased 
substance use problems and indicates the problem level associated with substance use.  
Three problem levels can be identified: 1) „intermediate‟; 2) „substantial‟; and 3) 
„severe‟.  Both measures were selected for use in the current study to provide a 
measure of substance use severity.   
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The Addiction Severity Index 5
th
 Edition (ASI; McLellan et al., 1992) is an interview 
designed to detect and measure the severity of potential problems in seven areas 
commonly affected by alcohol and drug use.  The authors of the ASI have indicated 
that it is acceptable to eliminate entire sections of the interview to meet the needs of a 
particular research question (McLellan et al., 1992).  For the present study, only the 
questions regarding alcohol/drug use status were incorporated to provide a measure of 
SUD severity.  This section asks participants to rate how important they currently 
regard treatment for their substance use, how troubled they have been in the past 30 
days by their substance use, and their age of onset of substance use. 
 
The Drinking Motives Questionnaire-Revised (DMQ-R; Cooper, 1994) contains 20 
items assessing reasons that might motivate individuals to drink alcoholic beverages. 
Participants rate on a 5-point Likert scale how frequently each of the 20 listed reasons 
motivate them to drink alcoholic beverages. The measure yields four scale scores 
reflecting different motives for drinking alcohol: enhancement, social, coping and 
conformity motives.  In the present study, the DMQ-R focused on motives for alcohol 
use in the past 12 months.  Internal reliabilities for the present sample were good 
(coping: α = 0.91; social: α = 0.95; enhancement: α = 0.72; conformity: α = 0.85) (see 
Chapter 5 for further information regarding internal reliability analysis).    
 
The Heroin Motives Questionnaire-Revised (HMQ-R).  In order to assess motives for 
using heroin, the DMQ-R was modified, changing „alcohol‟ to „heroin‟.  It was 
decided to use Cooper‟s (1994) measure in this way to broaden the nature of the 
current investigation to include those that misuse heroin.  This was deemed 
appropriate given that the DMQ-R captures motives that do not appear to be unique to 
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alcohol compared to other substances of choice.  Previous research has similarly 
adapted the DMQ-R to capture motives for cannabis use (Bujarski et al., 2012) and 
for use with a psychotic population (Spencer et al., 2002).   Effectively, the HMQ-R, 
yields the same four subscales as the DMQ-R.  Internal reliabilities for the present 
sample were variable (coping: α = 0.92; social: α = 0.84; enhancement: α = 0.64; 
conformity: α = 0.64).    
 
The Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983) is a 
14 item self-report questionnaire that consists of seven items for anxiety and seven for 
depression.  The items are scored on a four-point scale from zero to three.  Response 
choices vary by item, but higher numbers reflect increasing severity of symptoms.  
Item scores are added, giving subscale scores for anxiety and depression, ranging 
from zero to 21.  This measure was included to screen for symptoms of anxiety and 
depression in all participants.  This was decided based on the available literature, 
which reports a high prevalence of anxiety and depression in the SUD population (e.g. 
Merikangas et al., 1998; Grant et al., 2004).  PTSD patients typically report higher 
levels of anxiety and depression than non-PTSD patients (Schafer and Najavits, 
2007). Thus, it is important to identify anxiety and depression levels in both the PTSD 
group and the SUD only group to reduce confounding and to increase the 









Informed consent was obtained prior to completing any study procedures.  
Participants were made aware of their right to decline or withdraw consent at any time 
without explanation and informed that their decision on whether or not to participate 
in the study would not affect their current or future treatment.  Participants who had 
no history of trauma exposure, as indicated by the THQ, were not administered the 
PTSD measures.  Apart from this, all participants were administered the relevant 
questionnaires.  Interviews were conducted in various secure clinic spaces throughout 
the local area.  Responses to questionnaires were anonymous such that no participant 
could be matched to their responses.  Consent forms were stored separately from 
questionnaire responses to ensure anonymity.  Both consent forms and completed 
questionnaires were stored in a locked cabinet that only the researcher had access to.     
 
14.4 Power calculation & sample size  
 
An a priori power calculation was carried out using „GPOWER‟ version 2 (Erdfelder 
et al., 1996) to inform optimal sample size for the primary research hypothesis. Based 
on information provided by Cohen (1992), to detect a medium effect size of 0.6 for a 
t-test (one-tailed) with alpha set at 0.05, „GPOWER‟ indicated that 36 participants per 
group would be required to achieve power of 0.80. As the total sample consisted of 72 





14.5 Data analytic approach   
 
The data were analysed using SPSS for windows version 18. Associations between 
categorical variables were investigated using the chi-squared test.  For scaled 
variables, t-test analysis was used.  Associations between motives for substance use 
and PTSD symptoms were assessed with correlational analysis.  When data violated 
the assumptions of parametric tests (see Chapter 5, extended results for tests of 
parametric assumptions), both parametric and non-parametric equivalents were 
carried out and results compared.  Unless otherwise specified, the results of the 
parametric tests were in line with the non-parametric results.  Effect sizes are reported 




15.1 Demographic & descriptive data  
 
The data were collected from 72 participants; 46 (63.9 per cent) were male and 26 
were female (36.1 per cent).  The mean age of the total sample was 37.2 (SD 11.8).  
The mean age of the male participants was 39.8 (SD 10.3), and the mean age of the 
females was 32.5 (SD 13.3).  70 (97.2 per cent) participants were Caucasian and 2 
(2.8 per cent) were of Indian, black or other ethnic minority.  39 (54.2 per cent) 
participants were single, 25 (34.7 per cent) were married, cohabiting or in a long-term 
relationship, and 8 (11.1 per cent) were divorced.  54 (75 per cent) participants were 
unemployed, 8 (11.1 per cent) had full or part-time employment, and 10 (13.9 per 
cent) were in a training or educational programme. 35 (48.6 per cent) participants had 
no children, 23 (31.9 per cent) had children living at home or adult children not living 
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at home, and 14 (19.4 per cent) had children who were looked after and 
accommodated.     
 
37 (51.4 per cent) participants met diagnostic criteria for an alcohol related SUD and 
35 (48.6 per cent) met criteria for a heroin related SUD. 36 (50 per cent) met 
diagnostic criteria for Post Traumatic Stress Disorder (PTSD).  30 (83.3 per cent) of 
the 36 in the PTSD group reported experiencing four or more traumatic events, 2 (5.6 
per cent) reported three, and 4 (11.1 per cent) reported one.   Of those participants 
with PTSD, 19 (58.2 per cent) had an alcohol related SUD, and 17 (41.8 per cent) had 
a heroin related SUD. There was a significant association between PTSD status and 
employment status ( ² (4) = 11.8, p = 0.019, N = 72).  Participants with PTSD were 
approximately 8 (Odds Ration (OR) = 7.85) times more likely to be unemployed 
compared to participants without PTSD.  There were no significant differences 
between the groups for any other demographic variables.     
 
Table 5 includes descriptive data for participants with and without PTSD with regard 
to the following variables; 1) motives for substance use subscale scores as measured 
by the DMQ-R/HMQ-R, 2) HADS anxiety and depression scores, 3) substance use 
age of onset, and 4) hyperarousal, re-experiencing and avoidance scores as measured 







Table 5. Summary of descriptive data for clinical variables  
 PTSD (N = 36)        
M (SD)        
No-PTSD (N = 36)     
M (SD) 
DMQ-R/HMQ-R 
Coping 22.05 (3.19) 12.64 (3.68) 
Enhancement 11.03 (3.97)  12.0 (2.28) 
Social 8.5 (4.81)  13.08 (4.6) 
Conformity 6.92 (3.6) 7.72 (2.08) 
 
HADS 
Anxiety 17.31 (4.27)  9.89 (3.86) 
Depression 14.06 (5.85) 9.72 (3.43) 
 
Age of onset 14.86 (3.97) 19.28 (4.15) 
 
IES-R 
Hyperarousal 19.61 (4.76)  - 
Re-experiencing 25.68 (6.22) - 
Avoidance 24.28 (4.76)  - 
Total 69.47 (19.51)  - 
(DMQ-R = Drinking Motives Questionnaire-Revised, HMQ-R = Heroin Motives 
Questionnaire-Revised, HADS = Hospital Anxiety and Depression Scale, IES-R = 
Impact of Events Scale-Revised). 
 
15.2 Tests of the research hypotheses  
 
15.3 Comparison of motives for substance use between those with and without PTSD 
 
An independent samples t-test was conducted to compare coping-related motives for 
substance use scores between those with and without PTSD. Participants with PTSD 
endorsed coping-related motives for substance use significantly more than 
participants without PTSD and a large effect size was detected (t (70) = 11.57, p < 
0.001, d = 2.73).   
 
An independent samples t-test was conducted to compare social-related motives for 
substance use scores between participants with and without PTSD.  A large 
significant effect was found with participants in the PTSD group endorsing social-
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related motives for substance use significantly less than participants in the no-PTSD (t 
(70) = 4.12, p < 0.001, d = 0.97).  
 
Independent samples t-tests were carried out to compare enhancement and 
conformity-related motives for substance use scores between those with and without 
PTSD.  There were no significant differences between participants with and without 
PTSD for scores on the enhancement (t (58.72) = 1.245, p = 0.218) or the conformity 
(t (70) = 1.162, p = 0.250), motives for substance use subscales.  However, the non-
parametric equivalent (Mann-Whitney U) did find significant differences between the 
groups.  For the enhancement subscale, participants with PTSD scored significantly 
lower than those participants without PTSD and a small effect size was detected (U = 
436.5, p = 0.016, r = 0.28).  Participants with PTSD also endorsed conformity-related 
motives significantly less than those without PTSD and a medium effect size was 
detected (U = 406.5, p = 0.005, r = 0.33).    
 
15.4 Comparison of Substance use severity for those with and without PTSD 
 
  
Figure 2 displays the number of participants with and without PTSD who scored 
within the „intermediate‟, „substantial‟ and „severe‟ categories for substance use 
severity as measured by the MAST and the DAST.  There was a significant 
association between PTSD status and substance use severity categories ( ² (2) = 
20.62, p < 0.001, N = 72).  The calculated odds ratio (OR) indicated that participants 
with PTSD were 7.14 times more likely to fall within the „severe‟ category for 






























Figure 2. Number of participants with and without PTSD within each of the substance 
use severity categories as measured by the MAST/DAST. (MAST = Michigan 
Alcoholism Screening Test, DAST = Drug Abuse Screening Test).     
 
 
Figure 3 displays the number of participants with and without PTSD who responded 
„not at all‟, „slightly‟, „moderately‟, and „considerably‟ and „extremely‟ to question 
E24 of the ASI, which asked „how troubled or bothered have you been in the past 30 
days by alcohol/drug problems‟.  There was a significant association between PTSD 
status and responses to this question ( ² (4) = 23.62, p < 0.001, N = 72).  The 
calculated OR indicated that participants with PTSD were 7.12 times more likely to 
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Figure 3. Responses from participants with and without PTSD to the ASI question 
(E24) „how troubled or bothered have you been in the past 30 days by alcohol/drug 
problems‟. (ASI = Addiction Severity Index). 
 
 
Figure 4 displays the number of participants with and without PTSD who responded 
„not at all‟, „slightly‟, „moderately‟, „considerably‟ and „extremely‟ to question E25 of 
the ASI, which asked „how important to you now is treatment for alcohol/drug 
problems‟. Responses to this question were significantly associated with PTSD status 
( ² (4) = 25.41, p < 0.001, N = 72).  The OR indicated that participants with PTSD 
were 12.42 times more likely to have selected „extremely‟ in response to this question 
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 Figure 4. Responses from participants with and without PTSD to the ASI question 
(E25) „how important to you now is treatment for alcohol/drug problems‟. (ASI = 
Addiction Severity Index). 
 
 
15.5 Comparison of HADS scores for those with and without PTSD 
 
An independent samples t-test was conducted to compare anxiety and depression 
scores for those with and without PTSD.  As hypothesised, participants with PTSD 
obtained significantly higher anxiety (t (70) = 7.73, p < 0.001, d = 1.85) and 
depression (t (56.55) = 3.83, p < 0.001, d = 1.02) scores in comparison to participants 
without PTSD and large effect sizes were detected.   
 
15.6 Relationship between coping-related motives and IES-R subscale scores 
 
For participants in the PTSD group, a Pearson‟s correlation was carried out to test for 
associations between scores on the coping-related motives for substance use subscale 
and scores on each of the IES-R subscales (re-experiencing, avoidance, hyperarousal).  
No significant associations were found. 
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Additional Pearson‟s correlations were carried out to explore associations between the 
remaining motives (enhancement, social, conformity) for substance use scales and 
each of the IES-R subscales for the PTSD group. Scores on the enhancement-related 
motives for substance use subscale were significantly associated with avoidance 
scores (r = 0.391, N = 36, p = 0.018).  No further significant associations were 
observed between the motives and IES-R subscales.   
 
16. Discussion  
 
 
The goal of the current study was to compare motives for substance use in the 
presence and absence of PTSD in a treatment-seeking sample of SUD patients.  A 
large significant effect was found for the main research hypothesis.  Specifically, 
participants with comorbid SUD and PTSD endorsed coping-related motives for 
substance use significantly more than participants without PTSD.  Greater coping-
related motives for substance use among individuals with PTSD is consistent with 
prior work suggesting that individuals with PTSD use substances to cope (e.g. 
Grayson and Nolen-Hoeksema, 2005; Schuck and Widom, 2001).   Furthermore, 
findings indicated that participants with PTSD endorsed social, enhancement and 
conformity-related substance use motives significantly less than participants without 
PTSD.  This suggests that individuals with PTSD use substances for distinctively 
different reasons than those without PTSD.  This has important implications for 
treatment providers, particularly in light of the extant literature demonstrating that 
individuals with comorbid PTSD and SUD have poorer treatment prognoses (Ford et 
al., 2007; Najavits, 2005).  For example, it may be clinically useful to integrate coping 
skills into treatments for substance users with PTSD to help reduce their reliance on 
substances as a coping mechanism.  Such findings also highlight the importance of 
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carrying out individual formulations as generic treatments targeting substance use 
may fail to meet the needs of patients with comorbid PTSD and SUD.   
     
Results suggest that individuals with comorbid SUD and PTSD are likely to have 
more severe SUD symptoms than individuals without PTSD.  This finding is in line 
with previous research investigating severity of substance use for individuals with 
PTSD (e.g. Reynolds et al., 2004). It is also consistent with research demonstrating a 
link between PTSD and elevated use of substances (Villagonzalo et al., 2011).  Taken 
together, these findings suggest that psychological distress associated with exposure 
to trauma may be a risk factor for the progression of more severe substance use (Clark 
et al., 2001).  Substance use may reduce the negative emotional responses associated 
with PTSD, therefore increasing the likelihood of future substance use (Clark et al., 
2001).  Further, substance use is likely to provide short-term relief from the 
distressing symptoms associated with PTSD, but in the long-term symptoms will be 
exacerbated (Reynolds et al., 2004).  For instance, alcohol use is associated with 
memory impairment, and heroin use is associated with blunted affect, both of which 
are recognised features of PTSD (Reynolds et al., 2004). Similarly, impaired 
concentration, sleep disturbance, anxiety, irritability and intrusive images or 
flashbacks are features of PTSD, but may also accompany withdrawal from 
substances (Stewart et al., 1998).    Thus, a „vicious cycle‟ of PTSD symptomatology 
and substance use is likely to develop.     
 
In line with the research hypothesis, participants with PTSD were found to have 
higher anxiety and depression scores in comparison to individuals without PTSD.  
The presence of elevated anxiety and depression symptoms alongside PTSD 
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symptoms and a lack of adaptive coping mechanisms are all factors that are perhaps 
contributing to the heightened levels of severity of substance use observed in the 
current sample.  However, this is a speculation and further analysis with a larger 
sample and different research design is required to establish how much each variable 
contributes towards the relationship between PTSD and SUD.   That is, the design of 
the current study does not allow for causal inferences regarding the relation between 
PTSD symptoms and increased use of substances to cope. It is plausible that general 
heightened negative affect, as indicated by anxiety and depression scores in the 
current sample, result in elevated use of substances to cope.  Additionally, variables 
not accounted for in the current study such as, emotion regulation difficulties, may 
partially explain increased coping related motives for substance use in the presence of 
PTSD.     
 
Consisten] nb#‟.t with prior research investigating comorbid PTSD and SUD (e.g. 
Read et al., 2004; Smith et al., 2010), there was a trend for the PTSD group to have an 
earlier age of onset of substance use.  As such, individuals with PTSD tended to have 
a longer duration of lifetime substance use than those without PTSD.  However, this 
finding was not significant.  Additionally, patients with PTSD reported being 
significantly more troubled by their substance use in the past 30 days and viewed 
treatment for their SUD as significantly more important than their counterparts.   
 
PTSD symptoms, lengthy substance use histories, higher rates of anxiety and 
depression, and more severe SUD profiles will ultimately influence the success of any 
treatment targeting substance use.  As such, these are important variables that need to 
be taken into account by service providers.  Undergoing any type of treatment aimed 
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at reducing substance use without diagnosis and management of PTSD symptoms 
may result in a pattern where PTSD symptoms are exacerbated and trigger increased 
substance use and/or relapse (Reynolds et al., 2004; Najavits, 2005). Indeed, there is 
evidence to suggest that when patients become drug and/or alcohol free (or even 
begin to reduce their substance use), PTSD symptoms markedly increase (Najavits, 
2005).  This is most likely the result of PTSD symptoms not being identified and thus 
not being targeted.  Consequently, patients will quickly return to substance use in 
order to cope (Najavits, 2005).  This may decrease patients‟ beliefs that services can 
help them and create conflict between patients and service providers.  Treating SUD 
in the absence of any knowledge about PTSD symptoms is associated with higher 
relapse rates, poorer treatment outcomes, and ultimately greater use of Addiction 
Services (Najavits, 2005).  Taking all of this information together, this study 
highlights the importance of routinely screening patients accessing Addiction Services 
for trauma and PTSD.   
 
This study failed to find associations between coping-related motives for substance 
use and PTSD symptom clusters.  This finding is contrary to research carried out with 
adolescents where coping motives were positively associated with each of the PTSD 
symptom clusters (e.g. Dixon et al., 2009).  This is perhaps due to the differing 
sample characteristics and methodologies being used.  The current study included 
participants who met diagnostic criteria for a SUD and PTSD.  Dixon and colleagues‟ 
(2009) study included adolescents whose substance use and PTSD were established 
without use of formal diagnostic assessment.  Furthermore, in the current study 
enhancement-related motives for substance use related negatively to avoidance PTSD 
symptoms.  This is perhaps a reflection that patients with PTSD who have elevated 
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avoidance symptoms are motivated to use substances as a means of escaping or 
reducing the affective, behavioural and cognitive symptoms of PTSD.  In this sense 
the current finding that enhancement-related motives are inversely associated with 
avoidance symptoms is not surprising.  That is, patients with PTSD are not likely to 
be motivated to use substances to enhance their affect; in fact they wish to reduce 
their affect.  On the other hand, the negative association could be the result of patients 
who are more avoidant being less likely to be in situations where they might use 
substances to feel good.   
 
Results from the present study indicate that the self-medication hypothesis is a viable 
explanatory model for the relationship between SUD and PTSD.   Findings suggest 
that treatment seeking adults with comorbid SUD and PTSD use substances to cope 
with negative affect.  This is highlighted by the fact that those with PTSD in the 
current sample had evaluated levels of substance use severity, anxiety and depression 
scores.  Furthermore, the PTSD group scored significantly lower on the conformity, 
social and enhancement-related motives subscales than patients without PTSD.  This 
suggests that treatment-seeking adults with co-occurring PTSD and SUD have 
significantly different motivations for using substances in comparison to individuals 
without PTSD.  Although coping-related motives were not associated with PTSD 
symptom clusters, this might be due to the subgroup analysis being relatively 








In light of the self-medication hypothesis (Khantzian, 1997), it would have been of 
interest to compare age of onset of substance use to the age participants experienced 
their traumatic experience.  However, 83.3 per cent of the PTSD group reported 
experiencing multiple, repeated and prolonged trauma histories.  This meant that it 
was not possible to investigate the temporal course of trauma and substance use.  
 
The design of the current study did not take into account potential explanatory factors 
underlying the relationship between coping related motives for substance use and 
PTSD.  As such, it is difficult to draw firm conclusions regarding why individuals 
with PTSD use substances specifically for coping related reasons as compared to 
other motives for substance use.    
 
Although diagnostic instruments were used to assess the presence of PTSD and SUD, 
the reliance of self-report measures to capture symptomatology introduces bias to the 
study. The sample size, although adequate to test the main hypothesis, made subgroup 
analyses relatively underpowered.  Employing a cross-sectional design did not permit 
examination of the temporal relations of the variables studied.  The cross-sectional 
design also means that although the self-medication hypothesis is a plausible 
explanation for the current findings, the idea that there might be something inherent in 
the present samples coping styles, which makes them more vulnerable to developing 
PTSD cannot be ruled out.   
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The racial/ethnic homogeneity of the current sample limits the generalisability of the 
findings.  The sample consisted of adults with heroin/alcohol related substance use 
disorders and therefore may limit the generalisability of findings to other substances.  
Lastly, comparisons of motives for substance use amongst those with and without 
PTSD included both heroin and alcohol users.  Results may have been different if 
these substances were examined separately.  However, further exploratory analyses 
was undertaken to address this issue and results were relatively similar (see Chapter 5, 
extended results and discussion).      
 
16.2 Conclusions and implications for future research 
 
The current study contributes to the extant literature in that it supports previous 
findings suggesting that individuals with comorbid PTSD and SUD are motivated to 
use substances to cope with negative affect.  Although a number of methodological 
limitations are inherent in the present study, it also had a number of strengths.  It 
extends previous findings by using diagnostic instruments to confirm the presence of 
PTSD and SUD; by using a treatment seeking clinical sample representative of 
patients typically presenting to Addiction Services; and having a group without 
trauma histories to compare motives and symptomatology to which has the potential 
to reduce confounding.   
 
It appears acceptable to reject the null hypotheses and conclude that patients with 
PTSD have more severe substance use profiles, elevated symptoms of depression and 
anxiety and use substances to cope with negative affect.  However, the reasons why 
those with PTSD are more likely to endorse coping motives remains unclear.      
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It is possible that variables such as, anxiety sensitivity and emotion regulation 
difficulties, contribute to increased coping related motives for substance use in the 
current sample.  Accounting for such factors was out with the scope of the present 
investigation.  Future research incorporating a broader range of potential mediating 
variables may shed further light on the underlying relationship between PTSD and 
coping related motives for substance use.     
 
Bearing in mind the methodological limitations identified in the current study, future 
research should aim to replicate the findings, employ prospective designs, increase 
sample size to allow detailed investigation of specific substance use and associations 
with PTSD symptoms and general negative affect, and perhaps consider further 
aspects of substance use behaviour such as total consumption and frequency of use.  
When this has been achieved, future investigations can begin to pay attention to a 
broader range of potential mediating factors which may further increase 
understanding about the complex relationship between PTSD and SUD.   
 
Additionally, future research may benefit from investigating the current research 
question with qualitative methods.  This would not only complement the present 
findings but also perhaps increase understanding about participants‟ views on the 
connection between PTSD and SUD.  Indeed, whilst administering the questionnaires, 
participants consistently answered the research question in their own words.  
Inevitably, the quantitative questionnaires employed in the current study could not 
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17. Extended Results 
 
 
17.1 Parametric assumptions 
 
Prior to beginning analyses, tests of normality of distribution and homogeneity of 
variance were carried out to evaluate the data against assumptions for parametric 
tests.  The assumptions of parametric data were tested for those with and without 
PTSD (regardless of SUD type) and by SUD type (alcohol versus heroin, regardless 
of PTSD status). 
 
17.2 Distribution of data PTSD versus no-PTSD 
 
 
After inspection of histograms and Q-Q plots, the Kolmogorov-Smirnov (D) test was 
used to determine if the distribution of scores differed significantly from normality.  If 
the Kolmogorov-Smirnov test is significant (p < 0.05), data are said to have 
significantly non-normal distributions. 
 
 
Table 6 displays the results of the Kolmogorov-Smirnov tests for the motives, anxiety 









Table 6.  Distribution of scores on the DMQ-R/HMQ-R and HADS subscales for 
participants with and without PTSD. 
 PTSD (N = 36) No-PTSD (N = 36) 
  
D  
                                   
p  D   
                    
p 
DMQ-R/HMQ-R   
Coping 0.179 0.005 0.150 0.040 
Enhancement 0.195                               0.001 0.194 0.001 
Social 0.236                              < 0.001 0.236 < 0.001 
Conformity 0.297 < 0.001 0.114 0.200 
HADS     
Anxiety 0.210 < 0.001 0.147 0.049 
Depression 0.139 0.078 0.139 0.077 
(DMQ-R = Drinking Motives Questionnaire-Revised, HMQ-R = Heroin Motives 
Questionnaire-Revised, HADS = Hospital Anxiety and Depression Scale). 
 
 
17.3 Distribution of data heroin versus alcohol 
 
 
Table 7 displays the results of the Kolmogorov-Smirnov test for the motives, anxiety 
















Table 7. Distribution of scores on the DMQ-R/HMQ-R and HADS subscales by SUD 
type. 
 Alcohol related SUD  
(N = 37) 
Heroin related SUD  
(N = 35) 






0.163   0.014 0.161  0.022 
Enhancement 
 
0.238 < 0.001 0.108  0.222 
Social 
 
0.160   0.018 0.193  0.002 
Conformity 
 










0.160  0.017 0.141  0.076 
(DMQ-R = Drinking Motives Questionnaire-Revised, HMQ-R = Heroin Motives 
Questionnaire-Revised, HADS = Hospital Anxiety and Depression Scale). 
 
 
Table 8 displays the results for the PTSD group of the Kolmogorov-Smirnov test for 











Table 8.  Distribution of scores for the PTSD group on the IES-R subscales by SUD 
type  
 Alcohol related SUD  
(N = 19) 
Heroin related SUD  
(N = 17) 






0.246 0.004 0.178 0.159 
Avoidance 
 
0.266 0.001 0.186 0.123 
Hyperarousal 
 
0.240 0.005 0.266 0.002 
Total  
 
0.245 0.004 0.189 0.110 




17.4 Homogeneity of variance  
 
Levene‟s test was used to assess equality of variance for those with and without PTSD 
(regardless of SUD type) and by SUD type (alcohol versus heroin, regardless of 
PTSD status).  If Levene‟s test is significant (p < 0.05), this indicates that the 
assumption of equal variances has been violated. If this assumption is violated, it can 
be corrected by reporting the test statistic that does not assume equal variances 
(Welch‟s t-test).  Unequal variances are reported below.   
 
17.5 Motives for substance use subscales 
 
Variances were significantly different for the enhancement-related motives for 




Variances were also significantly different for the DMQ-R enhancement subscale 
between participants with and without PTSD (F (1, 37) = 7.33, p < 0.05). 
 
 
17.6 HADS depression scores 
 
 
Variances were significantly different for depression sores between participants with 
and without PTSD (F (1, 70) = 15.13, p < 0.01).   
 
Variances for the alcohol group were significantly different for depression sores 
between participants with and without PTSD (F (1, 37) = 9.09, p < 0.05).   
 
Variances for the heroin group were significantly different for depression sores 
between participants with and without PTSD (F (1, 35) = 14.3, p < 0.05).   
 
 
17.7 Further analyses  
 
 
Additional exploratory analyses were undertaken to investigate the relationship 
between PTSD status, motives for substance use, severity of substance use, HADS 
scores, PTSD symptom clusters and, specific substance use (alcohol versus heroin).   
 
17.8 Descriptive data  
 
 
Table 9 displays descriptive data for participants with and without PTSD in relation to 
SUD type (alcohol versus heroin) for the following variables 1) motives (DMQ-
R/HMQ-R) for substance use subscale scores, 2) HADS anxiety and depression 
scores, 3) substance use age of onset, and 4) the IES-R total, hyperarousal, re-
experiencing and avoidance scores. 
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Table 9. Descriptive data by SUD type for clinical variables for participants with and 
without PTSD. 
 PTSD  
alcohol 
  
(N = 19)       
  
 




(N = 18)  






(N = 17)     
 
 




(N = 18)  
 
 






22.05 (2.48) 10.89 (3.23) 22.05 (3.93) 14.34 (3.33) 
Enhancement 
 
12.21 (4.58) 11.94 (2.62) 9.7 (2.73) 12.05 (2.41) 
Social 
 









17 (4.49) 8 (3.32) 17.65 (4.12) 11.78 (3.47) 
Depression 
 
14.21 (5.69) 7.94 (2.75) 13.88 (6.2) 11.5 (3.17) 
 
 
Age of onset 
 
 





19.79 (4.42) - 19.41 (5.25) - 
Intrusion 
 
25.68 (6.22) - 25.47 (6.65) - 
Avoidance 
 
24.31 (14.29) - 24.23 (4.87) - 
Total 69.79 (22.86) - 69.11(15.63) - 
 
(DMQ-R = Drinking Motives Questionnaire-Revised, HMQ-R = Heroin Motives 
Questionnaire-Revised, HADS = Hospital Anxiety and Depression Scale, IES-R = 











An independent samples t-test was carried out to compare coping-related motives for 
alcohol use subscale scores between those with and without PTSD. Participants with 
PTSD endorsed coping-related motives for alcohol use significantly more than 
participants without PTSD and a large effect size was detected (t (35) = 11.82, p < 
0.001, d = 3.99).  
 
An independent samples t-test was carried out to compare social-related motives for 
alcohol use subscale scores between those with and without PTSD.  Participants with 
PTSD endorsed social-related motives for alcohol use significantly less than 
participants without PTSD and a large effect size was detected (t (35) = 4.57, p < 
0.001, d = 1.54).  
 
Independent samples t-tests were carried out to compare enhancement and 
conformity-related motives subscale scores for participants with and without PTSD.  
There were no significant differences between participants with and without PTSD on 
the enhancement (t (28.95) = 0.22, p > 0.05) or the conformity (t (35) = 0.969, p > 
0.05), motives for alcohol use subscales.  However, non-parametric equivalents 
(Mann-Whitney U) did find significant differences between the groups on the 
conformity subscale. Participants with PTSD scored significantly lower than those 
participants without PTSD and a medium effect size was detected (U = 255.5, p = 








An independent samples t-test was carried out to compare coping-related motives for 
heroin use subscale scores between those with and without PTSD. Participants with 
PTSD endorsed coping-related motives for heroin use significantly more than 
participants without PTSD and a large effect size was detected (t (33) = 11.82, p < 
0.001, d = 3.99).  
 
Independent sample t-tests were carried out to compare social and enhancement- 
related motives for heroin use subscale scores between participants with and without 
PTSD.  Participants with PTSD had significantly lower scores on the social (t (33) = 
2.204, p < 0.05, d = 0.77) and enhancement (t (33) = 2.7, p < 0.05, d = 0.94) motives 
for heroin use subscales than participants without PTSD, medium and large effect 
sizes were detected. 
 
An independent samples t-test was carried out to compare conformity-related motives 
for heroin use subscale scores between participants with and without PTSD. There 
were no significant differences between the groups on the conformity-related motives 
for heroin use subscale (t (33) = 0.78, p > 0.05).   
 




Figure 5 displays the number of participants with and without PTSD who scored 
within the „intermediate‟, „substantial‟ and „severe‟ categories for alcohol use severity 
as measured by the MAST.  There was a significant association between PTSD status 
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and substance use severity category ( ² (2) = 22.95, p < 0.05, N = 37). The calculated 
OR indicated that participants with PTSD were 13.68 times more likely to fall within 






























Figure 5.  Number of participants with and without PTSD within each of the alcohol 
use severity categories as measured by the MAST. (MAST = Michigan Alcoholism 
Screening Test).     
 
18.2 Comparison of responses to the ASI questions for alcohol users  
 
Figure 6 displays the number of participants with and without PTSD that responded 
„not at all‟, „slightly‟, „moderately‟, „considerably‟ and „extremely‟ to question E24 of 
the ASI which asked „how troubled or bothered have you been in the past 30 days by 
alcohol problems‟. Responses to this question were significantly different between the 
groups ( ² (4) = 13.31, p < 0.05, N = 37).  The calculated OR indicated that 
participants with PTSD were 7.94 times more likely to select „extremely‟ in response 
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Figure 6.  Responses from participants with and without PTSD to the ASI question 
(E24) „how troubled or bothered have you been in the past 30 days by alcohol 
problems‟. (ASI = Addiction Severity Index). 
 
Figure 7 displays the number of participants with and without PTSD that responded 
„not at all‟, „slightly‟, „moderately‟, „considerably‟ and „extremely‟ to question E25 of 
the ASI, which asked „how important to you now is treatment for alcohol problems‟. 
There was a significant association between PTSD status and responses to this 
question ( ² (4) = 20.17, p < 0.001, N = 37).  The OR indicated that participants with 
PTSD were 6.15 times more likely to select „extremely‟ in response to this question 
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Figure 8. Responses from participants with and without PTSD to the ASI question 









Figure 9 displays the number of participants with and without PTSD who scored 
within the „intermediate‟, „substantial‟ and „severe‟ categories for heroin use severity 
as measured by the DAST.  Although there were more participants with PTSD within 
































 Figure 9. Number of participants with and without PTSD within each of the drug use 
severity categories as measured by the DAST. (DAST = Drug Abuse Screening Test). 
 
 
18.4 Comparison of responses to the ASI questions for heroin users 
 
 
Figure 10 displays the number of participants with and without PTSD that responded 
„not at all‟, „slightly‟, „moderately‟, „considerably‟ and „extremely‟ to question E24 of 
the ASI, which asked „how troubled or bothered have you been in the past 30 days by 
drug problems‟. There was a significant association between PTSD status and 
responses to this question ( ² (3) = 12.93, p < 0.05, N = 35).  The calculated OR 
indicated that participants with PTSD were 9.15 times more likely to select 
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Figure 10. Responses from participants with and without PTSD to the ASI question 
(E24) „how troubled or bothered have you been in the past 30 days by drug problems‟. 
(ASI = Addiction Severity Index). 
 
 
Figure 11 displays the number of participants with and without PTSD that responded 
„not at all‟, „slightly‟, „moderately‟, „considerably‟ and „extremely‟ to question E25 of 
the ASI, which asked  „how important to you now is treatment for drug problems‟. 
There was a significant association between PTSD status and responses to this 
question ( ² (4) = 12.11, p < 0.05, N = 35).  The calculated OR indicated that 
participants with PTSD were 9.37 times more likely to select „extremely‟ in response 
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 Figure 11. Responses from participants with and without PTSD to the ASI question 




18.5 Comparison of HADS scores for those with and without PTSD for alcohol and 
heroin users  
 
For participants with an alcohol related SUD an independent samples t-test was 
conducted to compare anxiety and depression scores between those with and without 
PTSD. Participants with an alcohol related SUD and comorbid PTSD obtained 
significantly higher anxiety (t (35) = 6.89, p < 0.001, d = 2.32) and depression (t 
(26.29) = 4.22, p < 0.001, d = 1.65) scores as compared to participants without PTSD 
and large effect sizes were detected.   
 
For participants with a heroin related SUD an independent sample t-test was carried 
out to compare anxiety and depression scores between those with and without PTSD.  
Participants with a heroin related SUD and comorbid PTSD obtained significantly 
higher anxiety scores in comparison to participants without PTSD and a large effect 
size was detected (t (33) = 4.56, p < 0.001, d = 1.59).  Although participants with a 
 117 
heroin related SUD and comorbid PTSD had higher depression scores on average, the 
difference between the groups was not significant (t (23.5) = 1.41, p > 0.05). 
 
 
18.6 Comparison of motives for heroin use and alcohol use for those with PTSD 
 
 
Independent sample t-tests were carried out to compare DMQ-R and HMQ-R 
subscale scores amongst participants with PTSD.  There were no significant 
differences between the heroin and alcohol use motives subscales scores for 
individuals with PTSD. 
 
 
18.7 Relationship between specific substance use (alcohol versus heroin) and PTSD 
symptom clusters  
 
 
Associations between each of the motives for alcohol use subscale scores as measured 
by the DMQ-R and each of the PTSD symptom clusters as measured by the IES-R 
were evaluated with use of Pearson‟s correlation.  Enhancement-related motives were 
significantly associated with avoidance (r = 0.532, N = 19, p = 0.019), re-
experiencing (r = 0.565, N = 19, p = 0.012), and hyperarousal (r = 0.542, N = 19, p = 
0.017) symptoms of PTSD.  No further significant associations were observed 
between alcohol motives and IES-R scales.   
 
Associations between each of the motives for heroin use subscales as measured by the 
HMQ-R and each of the PTSD symptom clusters as measured by the IES-R were 
evaluated with use of Pearson‟s correlation.  No significant relationships were found 




18.8 Internal reliability of the DMQ-R and the HMQ-R 
 
 
The internal reliability of the DMQ-R and the HMQ-R measures were assessed using 
Cronbach‟s alpha.  The internal reliability was assessed for SUD group (alcohol 
versus heroin) for all participants and separately for the PTSD (alcohol versus heroin) 
and no-PTSD groups (alcohol versus heroin).  Several items were identified as having 
a corrected item-total correlation of 0.4 or below and were significantly reducing 
Cronbach‟s alpha.  In such cases, the item(s) were removed and analyses (independent 
sample t-tests) were then conducted without the problematic items.   
 
18.9 Internal reliability of the DMQ-R and HMQ-R for all participants  
 
 
Internal reliabilities for the DMQ-R were good (coping: α = 0.91; social: α = 0.95; 
enhancement: α = 0.72; conformity: α = 0.85).    
 
Internal reliabilities for the HMQ-R were variable (coping: α = 0.92; social: α = 0.84; 
enhancement: α = 0.64; conformity: α = 0.64).  Two items (questions 9 and 13) of the 
enhancement-related motives for heroin use were below 0.4 for the corrected item-
total correlation.  When these items were removed there continued to be no significant 
difference between participants with and without PTSD on the enhancement-related 
motives for substance use scale (t (57.64) = 0.84, p > 0.05).  
 
Three items (questions 2, 8 and 19) of the conformity-related motives for heroin use 
were below 0.4 for the corrected item-total correlation.  When these items were 
removed there continued to be no significant difference between participants with and 
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without PTSD on the conformity-related motives for substance use scale (t (70) = 0.6, 
p > 0.05). 
 
18.9.1 Internal reliability of the DMQ-R for participants with and without PTSD  
 
 
Internal reliability for each of the DMQ-R subscales for the PTSD group was variable 
(coping: α = 0.38; social: α = 0.95; enhancement: α = 0.74; conformity: α = 0.89).   
Three items (questions 6, 15 and 17) of the coping-related motives for alcohol use 
were below 0.4 for the corrected item-total correlation for the PTSD group.  
Differences between participants with and without PTSD remained significant for the 
coping-related motives for alcohol use subscale when these items were removed (t 
(24.74) = 14.93, p < 0.001, d = 6). 
 
 
Internal reliability for each of the DMQ-R subscales for the no-PTSD group was also 
variable (coping: α = 0.79; social: α = 0.86; enhancement: α = 0.70; conformity: α = 
0.64).  Zero items of the conformity-related motives were below 0.4 for the corrected 
item-total correlation.  
 
18.9.2 Internal reliability of the HMQ-R for participants with and without PTSD  
 
Internal reliability for each of the HMQ-R subscales for the PTSD was variable 
(coping: α = 0.82; social: α = 0.77; enhancement: α = 0.48; conformity: α = 0.72).   
One item (question 13) of the enhancement-related motives for heroin use subscale 
was below 0.4 for the corrected item-total correlation.  The finding that participants 
with PTSD had significantly lower scores on enhancement-related motives for heroin 
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use subscale than participants without PTSD remained true after item 13 was removed 
(t (33) = 3.48, p  < 0.05, d = 1.12) 
  
Internal reliability for each of the HMQ-R subscales for the no-PTSD group was also 
variable (coping: α = 0.86; social: α = 0.90; enhancement: α = 0.74; conformity: α = 
0.48).  One item (question 20) of the conformity-related motives for heroin use 
subscale was below 0.4 for the corrected item-total correlation.  When this item was 
removed, participants with PTSD continued to endorse conformity-related motives 
less than participants without PTSD and the difference remained non significant (t 


















19. Extended discussion  
 
19.1 Assumptions of parametric tests  
 
Data were checked for normality of distribution and for homogeneity of variances.  
Analyses revealed that scores on the anxiety scale of the HADS, and on the social, 
enhancement and coping-related motives for substance use subscales, were not 
normally distributed for participants with and without PTSD.  Scores on the 
conformity-related motives for substance use subscale were also not normally 
distributed for participants with PTSD. Variances were significantly unequal for 
scores on the depression scale of the HADS and for scores on the enhancement-
related motives for substance use subscale for participants with and without PTSD. 
 
Additionally, data were inspected by looking at SUD type (alcohol versus heroin).  
For participants with a SUD related to alcohol, scores were not normally distributed 
on any of the DMQ-R subscales, nor on the depression subscale of the HADS.  For 
the PTSD group with an alcohol related SUD, scores were not normally distributed on 
any of the IES-R subscales.  For participants with a SUD related to heroin, scores 
were not normally distributed on the coping, social and conformity-related subscales 
of the HMQ-R, nor on the anxiety subscale of the HADS. For the PTSD group with a 
heroin related SUD, scores were not normally distributed on the hyperarousal 
subscale of the IES-R.   
 
Variances were significantly different for scores on the depression subscale of the 
HADS and the enhancement-related motives for substance use subscale between 
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participants with and without PTSD.  Similarly, variances were significantly different 
for scores on the enhancement-related DMQ-R subscale between participants with 
and without PTSD. Depression scores for participants with a heroin and an alcohol 
related SUD also varied significantly between participants with and without PTSD.   
 
Many researchers would not recommend using parametric tests when assumptions of 
distribution and homogeneity of variance are violated (Norman, 2010).  However, the 
t-test is described as being sufficiently robust with respect to the assumption of 
normality (Norman, 2010).  This means that even deviations away from normality do 
not significantly impact on type-one error rates (Clark-Carter, 2010).  Clark-Carter 
(2010) notes that: 
 
“..contribution of scores should be normally distributed or at least the summary 
statistic being evaluated should be normally distributed which in the case of the t-test 
of means is likely to be true if the sample has at least 40 participants” (p.198)   
 
Additionally, Norman (2010) describes the idea of not being able to use parametric 
tests due to data being non-normally distributed as a myth.  Norman (2010) argues 
that: 
 
“…both theory and data converge on the conclusion that parametric methods 
examining differences between means, for sample sizes greater than 5, do not require 
the assumption of normality, and will yield nearly correct answers even for the 
manifestly non normal and asymmetric distributions…”  (p.92) 
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Furthermore, it is unlikely that two clinical samples, even when drawn from the same 
population, will have exactly the same variance (Clark-Carter, 2010).  Again, the t-
test has been shown to be robust enough so that the variances can be different to a 
certain degree and the test will not be badly affected (Clark-Carter, 2010).  
 
Consideration was given to the arguments for and against using parametric tests when 
assumptions are violated.  The decision was made to select parametric tests given that 
they are more powerful and appear to be sufficiently robust, even when dealing with 
non-normal data with unequal variances (Norman, 2010).  As a precautionary 
measure, non-parametric equivalents were also carried out.  For the majority of 
analyses both parametric and non-parametric tests produced the same results.  When 
differing results were obtained, the non-parametric equivalent was reported.      
 
19.2 Additional analyses 
 
The main analyses (Chapter 4), exploring differences between participants with and 
without PTSD, combined heroin and alcohol users.  As such, the PTSD group and the 
no-PTSD group included participants with both alcohol and heroin related substance 
use disorders.  Exploring the data in this way meant that scores on the DMQ-R and 
HMQ-R were combined and labelled as „motives for substance use‟.  Similarly, 
DAST and MAST scores were combined and labelled substance use severity scores.   
 
The possibility that examining SUD type separately might have affected the findings 
was considered and further analyses were carried out to investigate this (see extended 
results).  However, results demonstrated that whether combining or separating SUD 
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type, the finding that participants with PTSD endorsed coping-related motives 
significantly more than participants without PTSD remained.  There were some 
differences for the social, enhancement and conformity subscales when substances 
were examined separately.  For the alcohol group, no significant differences were 
found between scores on the enhancement-related DMQ-R subscale for participants 
with and without PTSD.  For the heroin group, there were no significant differences 
found between the conformity-related HMQ-R subscale for participants with and 
without PTSD.  When SUD type was combined (Chapter 4) there were significant 
differences between scores on all of the motives subscales.   
 
There were further differences in relation to substance use severity and HADS scores 
when substances were examined separately.  For the heroin group, there were no 
significant differences in terms of drug severity categories and for depression scores 
on the HADS for participants with and without PTSD.  For the PTSD group, heroin 
users scores on the DMQ-R did not significantly relate to any of the PTSD symptom 
clusters as measured by the IES-R.  For alcohol users, enhancement-related motives 
for alcohol use correlated negatively with all of the IES-R subscales.   
 
In general, results from the subgroup analyses were relatively in line with the results 
obtained when combining SUD type.  However, given that some discrepancies did 
emerge, it is difficult to conclude whether specific substance use does or does not 
influence the findings.  These discrepancies could be due to the subgroup analyses 
being relatively underpowered and thus a type two error may have occurred.  On the 
other hand, carrying out multiple tests on the same data increases the likelihood of a 
type one error.  Future research would benefit from exploring various substances with 
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large samples to establish whether specific substances do in fact produce differing 
results in terms of motivation for use.  This is potentially an important line of future 
enquiry given that existing evidence demonstrates an association between specific 
substances and PTSD symptoms (e.g. Tull et al. 2010; Smith et al. 2010; Villagonzalo 
et al. 2011). 
 
19.3 Internal reliability of the DMQ-R and HMQ-R  
 
The internal reliability of both the DMQ-R and the HMQ-R were examined in two 
ways: 1) by separating alcohol and heroin users regardless of PTSD status, and 2) by 
separating alcohol and heroin users with regard to PTSD status.  When the former 
method was used the internal reliability of all the DMQ-R subscales were good.  
However, the enhancement and conformity subscales of the HMQ-R were found to be 
somewhat less reliable. 
 
When the later method was employed, internal reliabilities for both the DMQ-R and 
HMQ-R were variable.  However, this analysis involved small numbers of 
participants and as such firm conclusions about reliability cannot be drawn. 
 
There are no alternative measures, to the author‟s knowledge, that capture motives for 
substance use.  Moreover, there are no measures in existence that have been 
specifically designed to capture motives for substance use in the presence of PTSD.  
As demonstrated, patients with comorbid SUD and PTSD have distinctively different 
motivations for using substances in comparison to patients without PTSD.   As such, 
it would be of benefit for future research to not only test the reliability of the motives 
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questionnaire used in the current study with a range of different substances but also, 
to develop one designed specifically for use with a PTSD population.  This would 
perhaps further increase understanding about the nature of the relationship between 
PTSD and SUD.  
 
Additionally, the finding that only the enhancement-related motives for substance use 
and in particular heroin use was associated with PTSD symptoms could perhaps be a 
reflection of the limitations of the DMQ-R and HMQ-R.  That is, the coping-related 
motives subscale measures internal, emotion regulation motives.  Participants with 
PTSD had elevated levels of anxiety and depression.  As such, participants with 
PTSD may have endorsed coping-related motives more than their counterparts, as 
they are motivated to use substances to cope with the negative affect associated with 
PTSD, such as increased anxiety and depression.  On the other hand, a measure 
capturing motives for substance use in the context of PTSD symptoms may have 
produced different findings.  For an illustrative example, instead of asking 
participants to rate how often they have used alcohol in the past year to “forget their 
worries”, one could ask how often they have used alcohol in the past year to “forget 
about bad memories”.   This would help to establish whether use of substances relates 
to regulating general negative affect, or to specific symptoms associated with PTSD 
(e.g. re-experiencing, avoidance, hyperarousal).    
   
19.4 Conclusion & recommendations 
 
Although data used in the current study violated the assumptions of parametric tests, 
precautionary measures were taken to reduce the likelihood of committing a type one 
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error.  Furthermore, parametric tests are robust enough that violations of assumptions 
should not significantly influence the findings.   
 
Further sub-group analyses were carried out to investigate whether specific substance 
use produced a differential pattern of results.  Some differences were found when 
heroin and alcohol were examined separately. However, the subgroup analyses 
involved small samples and as such firm conclusions cannot be drawn about specific 
substance use.  Future research would benefit from investigating differing substances 
with larger samples. This would perhaps shed further light on the association between 
PTSD and SUD.   
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Appendix 2: Table 2. Extraction of Relevant Information from Included Studies. 
Table 2. 
Study     
Research Objectives  




Analysis Key Findings 
Back et al., 
(2000) 
To compare substance 






with & without lifetime 
PTSD 
USA 





















- TLFB  












Individuals with PTSD (compared to those 
without PTSD) had: 
 
- Significantly higher trauma exposure 
 
- Earlier age of first assault 
 
- More severe symptomatology 
 







Back et al., 
(2005) 
To examine order of 
onset differences in 
clinical presentation & in 
response to CBT (for 
USA RCT 











- PTSD most often preceded alcohol 
dependence 
 
- Females with primary AD & males with 
 155 
alcohol use) in 
individuals with alcohol 
dependence (AD) & 
PTSD 

























primary PTSD presented as more distressed 
and/or depressed than counterparts at baseline 
 
- Observed relationship between increased 
alcohol intake & higher PTSD symptoms 
 
- Primary PTSD group derived greater benefit 
from CBT than primary AD group. 
Back et al., 
(2006) 
To investigate the 
temporal course of 




in a 12-week outpatient 
treatment study 








sertraline in the 
treatment of 
comorbid 






























- Alcohol symptoms tended to start improving 
either before or in conjunction with PTSD 
symptoms 
 
- Improvements in PTSD symptoms had a 
greater impact on improvement in AD 
symptoms (compared to the reciprocal 
relationship) 
 
- Improvements in hyperarousal PTSD 
symptoms, in particular, were related to 





et al., (2009) 
To examine gender 
differences in 
mechanisms that may 
explain the association 
between PTSD & SUD  


























- PTSD symptoms were associated with a lack 
of clarity & awareness of emotions as well as 
difficulty controlling impulsive behaviours 
when distressed 
 
- For females, the association between PTSD 
symptoms & substance use frequency was 
partially accounted for by difficulties 
controlling impulsive behaviour when 
distressed 
 
- For males, the relationship between PTSD 
symptoms & substance use frequency was 
partially explained by lack of emotional 
awareness & clarity of emotions. 
Clark et al., 
(2001) 
To investigate the extent 
to which violent 
traumatic events, PTSD, 
& recency of PTSD-
related symptoms 
contribute to drug use 
severity in methadone 
treatment patients. 
USA Observational 150(91M:59M) 
(Participants 












with a standard 
psychosocial 
treatment) 


























- 29% of participants were classified as having 
had a diagnosis of PTSD at some point in their 
life 
 
- 55% of those with a history PTSD reported 
PTSD symptoms in the past six months 
 
- Those meeting the criteria for PTSD reported: 
a greater total number of traumatic events & 
were more likely to be diagnosed with 
depression & dysthymia than those who did not 
meet diagnostic criteria  
 
- The occurrence of PTSD-related symptoms 
was associated with greater drug abuse severity 
after controlling for gender, depression, & 





To investigate the 
association between 
PTSD & the severity & 
course of addiction & 
psychopathology in 
patients with PTSD, 
subsyndromal PTSD & 
in those with a history of 
trauma exposure without 
PTSD 


























- Prevalence of PTSD was higher in drug & 
combined alcohol & drug dependence than in 
alcohol dependence 
 
- The more strictly PTSD was diagnosed the 
clearer the associations with social status, 
addiction, & psychopathology 
 
- PTSD was an independent risk factor for an 
unfavourable course & outcome of SUD 
 
- Subsyndromal PTSD was associated with a 
higher degree of psychopathology but the 






Evren et al.,  
(2010) 
To evaluate the 
prevalence of lifetime 
PTSD in male alcohol-
dependent inpatients & 
to investigate the 
relationship of PTSD 
with alexithymia & 
temperament & character 
dimensions. 
























- 32.1% of participants had lifetime PTSD.   
 
- Individuals with PTSD had higher scores of 
alexithymia, novelty seeking, harm avoidance 
and self-transcendence.  
 
 - ‘Difficulty in identifying feelings’ predicted 
PTSD. 
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Hien et al., 
(2010) 
To examine the temporal 
course of improvement 
in symptoms of PTSD 
and SUD among woman 
in outpatient substance 
abuse treatment.  


















liner model  
- PTSD severity reductions were associated 
with substance use improvement.   
 
- There was minimal evidence that substance 










Mills et al., 
(2006) 
To examine the impact 
of PTSD on 2-year 
treatment outcomes for 
heroin dependence. 





























- Despite improvements in substance use, 
PTSD was associated with continued 
impairment in occupational, physical & 
psychosocial functioning throughout the 2-year 
follow-up.  
 
- At 2-year follow-up, both those with & 
without current PTSD were equally as likely to 
















To compare SUD 
treatment outcomes & 
relapse features in male 
veterans who had, no 
history of trauma 
exposure, PTSD, & a 
history of trauma 
exposure but no PTSD. 


























- The groups did not differ on length of 
abstinence, relapse prevalence or severity. 
 
 - SUD-PTSD and SUD-trauma groups reported 
more depression, anxiety, PTSD and total 
psychiatric symptoms prior to & following 
relapse than the SUD-only group.   
 
- PTSD symptoms were associated with greater 
risk of relapse in interpersonal & negative 











al.,  (2007) 
To examine precipitants 
& characteristics 
associated with relapse 
in those with and without 
PTSD. 
USA Observational 65 (57F: 8M) Base-line & 




















-T hose with PTSD were less likely to report 
first substance use triggered by cue-based urges 
& more likely to report use in response to 
negative emotions of an interpersonal nature 
than those without PTSD 
 
- Greater subjective urges right before using, 
greater efforts to obtain substances & more 
likelihood to use to intoxification were 
associated with PTSD 
 
- Those with unremitted PTSD at follow-up 
reported poorer outcome & self-efficacy 
expectations than those without PTSD or with 
remitted PTSD.  
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Read et al., 
(2004) 
To examine the 
concurrent & prospective 
associations between 
SUD & PTSD & the 
symptoms & 
mechanisms underlying 
these associations.  






























- Baseline PTSD status did not predict 
substance use outcome.   
 
- Change in PTSD status over follow-up 
predicted substance use outcomes; those with 
unremitted PTSD (present at baseline & follow-
up) demonstrated poorer SUD outcome than 
those with remitted PTSD.  
 
- General psychiatric distress at follow-up was 
associated with poorer outcomes, and such 
distress mediated the association between 









To investigate the 
prevalence of co-morbid 
PTSD & SUD in a 
inpatient population; to 
identify the 
characteristics, severity 
& types of trauma 
experiences; to compare 
substance use history, 
psychological/psychiatric 
& social variables in 
those with and without 
PTSD.   
























- 38.5% met criteria for current PTSD 
- 51.9% met criteria for lifetime PTSD 
- PTSD was significantly associated with more 
lifetime & psychiatric problems  
- There was a trend for those with PTSD to 
have higher substance use severity scores than 
those without PTSD 
 
- Those with PTSD reported: 
 Greater impairment in their social, 
occupational and family responsibilities & 
more distress associated with their target 
trauma & with memories of the target trauma 
compared to those without PTSD. 
- There were minimal differences with 
psychiatric symptomatology between those 










To evaluate anxiety 
sensitivity, cognitive 
avoidance, & 
alexithymia & their 
relationship to PTSD & 
alcohol use concurrently 
and prospectively.    































- Anxiety sensitivity accounted for a significant 
amount of variance in PTSD symptom cluster 
severity 
 
- Cognitive avoidance accounted for additional 
variance with concurrent PTSD avoidance 
symptoms 
 
- Anxiety sensitivity & cognitive avoidance 
were not associated with alcohol use indices 
 
- Alexithymia was redundant with cognitive 
avoidance and was not included in the 



































To investigate the 
relationship between 
PTSD & lifetime 
histories of crystal 
methamphetamine (CM) 
use.  
USA Observational 89(66F: 23 M) Trauma 
exposure, PTSD 
symptom 

















- Individuals with PTSD were significantly 
more likely to report CM use than trauma-
exposed individuals without PTSD 
 
- CM users with PTSD reported a longer 
duration of CM use than trauma-exposed CM 
users without PTSD 
 
- PTSD avoidance & hyperarousal symptoms 
were related to CM use. 
Tull et al., 
(2010) 
To examine the 
relationship between 
severity of Post 
Traumatic Stress (PTS) 
symptom clusters and 
heroin, crack/cocaine, 
and alcohol dependence.  
































- Hyperarousal & avoidance symptoms were 
associated with heroin dependence.   
 
- There was no evidence found for a 
relationship between PTS symptom clusters & 







et al., (2011) 
To explore the 
relationship between 
substance abuse and 
PTSD symptom clusters 
in a methadone 
maintenance population. 



















- PTSD symptom severity was strongly linked 
with severity of marijuana use 
 
- Severity of opiate, amphetamine, and 




To compare high-risk 
triggers and substance 
use situations among 
individuals with AD or 
cocaine dependence 
(CD), with or without 
comorbid PTSD.  











- Individuals with PTSD compared to those 
without PTSD reported greater use of 
substances in response to negative situations  
 
- CD individuals with PTSD reported greater 
use of cocaine during pleasant times with others 
compared to those without PTSD  
(SCID-R = The Structured Clinical Interview for the DSM-III-R, ASI = The Addiction Severity Index, CEQ = Cocaine Experience Questionnaire, QCH = Quantitative 
Cocaine History, TLFB = Time-Line Follow-Back, NWS = The National Women’s Study, DIS = Diagnostic Interview Schedule, BDI = Beck Depression Inventory, HamD = 
Hamilton Depression Scale, SCL-90-R = The Symptom Checklist 90, Revised, SCID = The Structured Clinical Interview for the DSM-IV, CAPS = Clinical Administered 
PTSD Scale, MISS = The Civilian Mississippi Scale for PTSD, IES = Impact of Events Scale, PCL = Posttraumatic Stress Disorder Checklist – Civilian Version, DERS = 
Difficulties in Emotion Regulation Scale, CDIS = Computerised Diagnostic Interview Schedule, IDCL = The International Diagnostic Checklists, PDS = The Posttraumatic 
Diagnostic Scale, BPRS = Brief Psychiatric Rating Scale, SAM = The Self-assessment manikin, TAS-20 = Toronto Alexithymia Scale, TCI = Temperament Character 
Inventory, CIDI = Composite International Diagnostic Interview, OPTI = Opiate Treatment Index, SF-12 = Short Form – 12, IPDEQ = International Personality Disorders 
Examination Questionnaire, SSAGA = Semi Structured Assessment for the Genetics of Alcoholism, lifetime version, BSI = Brief Symptom Inventory, CCAI = Contextual 
Cue Assessment Interview,  RI = Relapse Interview, LSC-R = The Life Stressor Checklist-Revised, THQ = The Trauma History Questionnaire, PSS-1 = Posttraumatic Stress 
Symptom Scale – Interview version, TMTC = Traumatic Memory and Trauma Characteristics, PCL-C = PTSD Checklist – Civilian Version, ANSI = The Anxiety Sensitivity 
Index, WBSI = The White Bear Suppression Inventory, TCQ = Thought Control Questionnaire, PACS = The Penn Alcohol Craving Scale, AUDIT = The Alcohol Use 
Disorders Identification Test, MINI = The Mini International Neuropsychiatric Interview, TEQ = Traumatic Events Questionnaire, CES-D = Centre for Epidemiological 


































Back et al., (2000) 1 2 2 2 2 2 1 0 2 2 16 
Back et al., (2005) 1 2 2 2 1 2 1 0 1 1 13 
Back et al., (2006) 1 2 2 1 1 2 1 0 2 1 13 
Bornovalova et al., (2009) 2 1 1 1 2 0 1 0 2 1 11 
Clark et al., (2001) 1 2 1 2 2 2 1 0 1 2 14 
Driessen et al., (2008) 2 2 2 2 2 2 2 0 1 2 17 
Evren et al.,  (2010) 1 2 1 2 2 1 1 0 2 1 13 
Hien et al, (2010) 1 2 2 2 2 2 2 0 2 2 17 
Mills et al., (2006) 1 1 1 1 2 0 2 0 2 2 12 
Norman et al., (2007) 2 1 1 1 2 1 1 0 1 2 12 
Ouimette et al.,  (2007) 1 1 1 1 2 0 1 0 1 1 9 
Read et al, (2004) 1 1 1 1 0 0 0 0 1 1 6 
Reynolds et al., (2004) 2 1 1 2 2 2 1 2 2 1 16 
Simpson et al., (2006) 2 1 2 1 2 0 1 0 1 2 12 
Smith et al., (2010) 2 1 1 2 1 1 1 0 2 1 12 
Tull et al., (2010) 2 2 2 1 1 1 1 0 1 2 13 
Villagonzalo et al., (2011) 2 1 1 1 2 0 1 0 2 2 12 
Waldrop et al., (2007) 1 1 1 1 1 0 1 0 0 1 7 
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Appendix 6: Copy of all measures used in the empirical 
study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
